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REVIEW OF THE LITERATURE
Hormonal Regulation of Growth
Introduction
Growth is a complex, highly integrated process involving interactions
among nutrients, environment, genotype, enzymes, and many different metabolic
hormones. Interrelationships among hormones, as well as the interaction
between circulating hormones and their receptors, are critical factors involved in
normal growth and development. Hormonal stimulation and regulation of growth
are primarily carried out by growth hormone and the somatomedins, which will
be the focus of this chapter. However, production of these hormones and their
receptors is regulated by many other hormones. Table 1 summarizes many of
the effects of hormones which have regulatory roles in the growth axis.
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GH. The A and B forms were characterized by a leucine and valine amino acid.
respectively, at amino acid position 127. A variant bovine mRNA. resulting from
missed splicing of the last intron and a frameshift in the last exon, was reported
by Hampson and Rottman (1987). However, the predicted higher molecular
weight protein has not been isolated.
The three dimensional structure of GH has been described in porcine
(Abdel-Meguid et al.. 1987) and in humans (de Vos at at., 1992). GH is
characterized as a four-helical bundle. The helices are arranged in an up-up-
down-down configuration, which differs from the more usual up-down-up-down
configuration. Porcine and human GH configurations differ at the connections
between helices 1 and 2 (although this observed difference may be a result of
receptor binding in human GH). and the connection between helices 2 and 3 (de
Vas et aI., 1992). The primary structures of GH show a high degree of homology
among higher vertebrates as previously compared by Palanivelu and
Dharmalingam (1993).
Growth Hormone Gene. The bovine GH (bGH) gene has been
sequenced by Woychik et al. (1982) and Gordon et al. (1983). The bGH gene is
approximately 1.8-kb and is composed of five exons (13, 161, 117, 162 and 201
bp each) and four introns (248,227,229 and 274 bp each). The gene has been
assigned to bovine chromosome region 19q26-qter by Hediger et at (1990).
Several restriction fragment length polymorphisms (RFLPs) in the bGH
gene have been identified in different breeds of cattle. These RFLPs represent
two different polymorphisms in the bGH gene: an insertion/deletion of
approximately O.9-kb in the 3' region of the gene, and a polymorphic Mspl
restriction site in the third intron (Hoj at aI., 1993). These bGH RFLPs are
summarized in Table 2.
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Table 2. Summary of bGH RFLPs identified in cattle.
Restriction Enzyme Breed Reference
BglIl, BamHI, EcoRI.
Hindlll









Hoistein-Baladi x Hallerman at al. (1987)
Hereford-Simmental-
Charolais
Holstein Cowan at al. (1989)
Belgian Blue Hilbert et al. (1989)
Angus, Brahms. Rocha at al. (1992a)
Hereford. Holstein,
Jersey
Red Danish Hoj et al. (1993)
Polymerase chain reaction (PCR) has also been used to detect
polymorphisms in the bGH gene. Kirkpatrick (1992a) reported a single strand
conformation polymorphism (SSCP) in the fourth intron. A polymorphic Mspl
restriction site in PCR products was described by Hoj et al. (1993) and Zhang at
al. (1993). Lucy et al. (1991) and Zhang et al. (1992) described another PCR-
based method using the restriction enzyme Alul to distinguish the A and B forms
of bGH originally described by Seavey et al. (1971).
Secretion of Growth Hormone. GH is secreted by somatotropic cells of
the the anterior pituitary. The regulation of GH is primarily controlled by two
hormones secreted by the hypothalamus: Growth Hormone Releasing Factor
(GRF), which stimulates GH secretion, and Growth Hormone Release Inhibitory
Factor (Somatostatin; SRIF), which inhibits GH secretion (Buonomo and Baile,
1990).
SRIF was first identified by Krulich et al. (1968) and was further purified
and sequenced from Qvine pituitary by Brazeau at al. (1973). SRIF is found in
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high concentrations in the central nervous system (eNS), pancreas and gut.
Administration of SRIF blocks secretion of endogenous as well as GRF-
stimulated GH secretion, while immunoneutralization against SRIF increases
plasma GH concetration (see Buonomo and Baile, 1990).
The presence of GRF was first described by Deuben and Meites (1964),
and the GRF protein was sequenced from pancreatic tumor tissues by Guillemin
et al. (1982) and Rivier et al. (1982). Ling et al. (1984) showed that human
hypothalamic GRF was identical to pancreatic GRF. Administration of
exogenous GRF stimulated growth in rats, GH-deficient children and swine,
while immunoneutralization against GRF resulted in decreased GH and
circulating IGF-1 concentrations in cattle, as well as decreased growth in rats
and cattle (see Buonomo and Baile, 1990).
GH is secreted in a pulsatile manner which is regulated by episodic
secretions of GRF and SRIF (Frohman at aI., 1990). GRF peaks measured from
the hypophyseal portal system were significantly correlated with GH peaks in
sheep, but no correlation was observed between SRIF troughs and GH peaks
(Frohman at aI., 1990). These results indicate that GRF is a stronger regulator
of pulsatile GH release than SRIF in sheep (Buonomo and Baile, 1990). The
secretion of GRF and SRIF is regulated by a number of factors (see Buonomo
and Baile, 1990, for review) including: neurotransmitters (histamine,
acetylcholine, gamma amino butyric acid (GABA), and serotonin), neuropeptides
(vasoactive intestinal peptide (VIP), motilin, galanin, substance P, and
neurotensin), opiod peptides, a-adrenergic agonists, cytokines (tumor necrosis
factor alpha, interleukin-1~, and interleukin-6), and glucocorticoids. GH is also
capable of regulating its own secretion through negative feedback on the
hypothalamus (Tannenbaum, 1980), although the exact mechanism of this
feedback is not known. Long term negative feedback may also be carried out by
s
IGF-I on the hypothalamus and pituitary (Buonomo and Baile, 1990). Finally,
GH secretion is influenced by changes in nutritional or metabolic status (Driver
and Foster, 1981). Effects of these regulators on GH regulation are summarized
in Table 3.
Table 3. Regulators of GH secretiona.
















Hypoglycemia decrease increase SRIF
Free Fatty Acids decrease hypothalamus and pituitary










aReferences are presented in review by Buonomo and Baile, 1990.
*opposite effect observed in rats
Biological Actions of GH
Metabolic. GH has regulatory actions on metabolism and growth.
Metabolic effects of GH may be described as insulin-like and insulin-antagonistic
(diabetogenic) for acute and chronic effects, respectively (see Press, 1988).
Acute, insulin-like effects of GH are observed 1 to 2 hours after GH
administration and are more apparent in GH deficient animals. It has been
suggested that normal levels of endogenous GH prevent the expression of
insulin-like effects of GH (Isaksson et al.. 1985). Some transient effects
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observed as a result of GH administration in GH deficient animals include an
increase in amino acid incorporation into proteins, a decrease in lipolysis and
free fatty acids, and a decrease in plasma glucose (Press. 1988).
Chronic elevation of GH levels results in increases in insulin-like growth
factors (IGFs) and insulin. IGF is known to be a mediator of growth stimulating
effects of GH (see below), and it has been suggested that insulin may be a
mediator of the anabolic effects of GH. Many of the metabolic changes
observed after chronic elevation of GH levels are summarized in Table 4.
Table 4. Metabolic effects of GHa.
Tissue Physiological process affected
Adipose ~ Glucose uptake and glucose oxidation
~ Lipid synthesis if in positive energy balance
~ Lipogenic enzyme activity
~ Basal lipolysis if in negative energy balance
~ Insulin stimulation of glucose metabolism
~ Catecholamine-stimulated lipolysis
~ Ability of insulin to inhibit lipolysis
Liver ~ Glucose output
~ Ability of insulin to inhibit gluconeogenesis
Intestine ~ Absorption of Ca and P required for lactation or
growth
~ Ability of 1,25 vitamin 03 to stimulate calcium-
binding protein .




__________t FFA oxidation if in negative energy balance
8Adapted from Etherton and Smith (1991).
Growth. Salmon and Oaughaday (1957) showed in hypophysectomized
rats that increased sulphation of costal cartilage, which was known to be closely
correlated with growth rate, was stimulated by serum from GH treated animals,
but not from GH itself. The unknown "sulphation factor" was later termed
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"somatomedin" (Daughaday at al., 1972), and has since been identified as
insulin-like growth factor I (IGF-I; Klapper et at, 1983). Since this work, the
somatomedin hypothesis, which suggests the growth promoting actions of GH
are carried out by circulating somatomedins rather than GH itself~ has been
widely accepted.
Although many of the growth promoting effects of GH are known to be
carried out by increased levels of plasma somatomedins, direct stimulatory
effects of GH have been demonstrated. Isaksson et al. (1982) and Russell and
Spencer (1985) demonstrated that hGH administered directly into the cartilage
growth plate of the proximal tibia of hypophysectomized rats resulted in an
increase in unilateral longitudinal bone growth. Overall growth in the treated
animals did not increase, indicating the observed response was not caused by
indirect effects of GH on serum somatomedins. It was suggested that the
increased bone growth was a result of increased cell proliferation in the growth
plate caused by GH. Lindahl et al. (1986) showed that GH can potentiate the
formation of large size chondrocyte colonies from chondrocyte cells isolated
from epiphyseal plates of tibia of normal rats. The authors suggested that GH
stimulates differentiation of epiphyseal chondrocyte stem cells or early
proliferative chondrocytes, supporting previous evidence for a direct stimulatory
effect of GH on longitudinal bone growth. GH was also shown to stimulate DNA
synthesis in cultured chondrocytes from rabbit ear and rat rib growth cartilage
(Madsen at aI., 1983). Finally, the visual demonstration of GH receptors on
human growth plate chondrocytes by Werther et al. (1990) provides additional
evidence for direct actions of GH on chondrocytes.
Circulating Growth Hormone Concentrations and Growth. Serum GH
concentrations have been shown to be correlated with growth in cattle. Verde
and Trenkle (1987) found significantly higher serum GH concentrations in steers
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with a high genetic potential for growth as compared to steers with a low genetic
potential for growth. Similar results were observed by Ohlson et at (1981)
where higher GH concentrations were found in Simmental than Hereford bulls,
and Grigsby and Trenkle (1986) where Simmental were reported to have higher
GH concentrations than Angus or Limousin steers.
Arbona et al. (1988) compared GH secretory patterns and metabolic
clearance rate between Landrace pigs selected 3 generations for increased 200-
day weight, and randomly selected Landrace controls. Significantly greater
baseline GH concentrations were observed in the selected pigs compared to the
controls, but no differences in overall mean concentrations of GH, frequency of
secretory episodes, amplitude of GH peaks or metabolic clearance rate were
observed. Norton et al. (1989) studied GH plasma concentrations in two lines of
pigs divergently selected for slow growth rate and fast growth rate for 5
generations. In contrast to the results reported by Arbona et al. (1988), Norton
et al. (1989) observed significantly greater mean GH concentrations and plasma
GH profiles in the line selected for slow growth rate compared to the line
selected for fast growth rate.
Goddard et al. (1988) measured circulating GH concentrations in broilers
selected for an increase in growth, broilers in which selection pressure was
relaxed, and in White Leghorns. Goddard at al. (1988) found the highest GH
levels in lines of birds with the slowest growth rate. Results from this study also
indicated that selection within a genotype for a higher growth rate resulted in
lower mean plasma GH levels. In reviewing related studies, Goddard et al.
(1988) concluded that heavy lines have lower plasma GH levels regardless of
the mode of increased growth (Le. selection, introduction of a dwarfing gene, or
natural genotype differences).
9
Pidduck and Falconer (1978) studied the effects of the dwarf gene dw.
which causes hypopituitary dwarfism and a lack of GH, on GH status in three
lines of mice previously selected for divergent growth rates. Repeated
backcrossing was used to introgress the dw gene into lines of mice selected 21
generations for high or low 6-week body weight, and non-selected controls.
Results indicated that increased growth in the large strain was partially due to an
increase in amount or activity of circulating GH, while the decrease in growth
observed in the small strain was due to a reduced sensitivity of target organs to
GH.
Medrano et al. (1991) investigated the effects of the high growth gene
(hg) on circulating and pituitary GH levels in three different genetic backgrounds
of mice. The study also considered the effects of the hg gene on plasma levels
of insulin-like growth factor I (IGF-I). The hg gene dramatically increases
postweaning growth rate and mature size (Bradford and Famula, 1984) without
significantly altering overall body composition (Calvert at aI., 1985) in mice.
Results from this study showed that mice carrying the hg gene had decreased
levels of pituitary and plasma GH. and GH was not secreted in the normal
pulsatile pattern. It was also observed that the interaction between different
genetic backgrounds (selected and non-selected for high growth) and the hg
gene was significant. This interaction may have resulted from negative feedback
of increased IGF-Ilevels on GH production, or from other genetic mechanisms
which developed due to selection pressures and interacted with the hg gene to
regulate GH production.
Elevated GH Levels. Exogenously administered GH has been shown to
stimulate nitrogen retention and body weight gain in swine, sheep and cattle
(Davis et aI., 1970; Machlin, 1972; Moseley at aI., 1982; Muir et aI., 1983; Chung
et at, 1985; Etherton at aI., 1987; Johnsson et aI., 1987; Beermann at aI., 1990;
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Hancock and Preston, 1990; Smith and Kasson. 1990; Moseley at aI., 1992).
Average daily gain and feed efficiency improve in cattle treated with bGH, but
studies have reported variability in the magnitude of response due in part to
different management conditions among studies (Moseley at aI., 1992). Average
daily gain and feed efficiency in cattle are improved by bGH administration in
either the growing or finishing phase (Moseley at al.. 1992).
The development of transgenic animals has provided another method by
which to study the effects of increased levels of GH. Palmiter at al. (1982)
reported the production of transgenic mice which expressed high levels of rat
GH from a mouse metallothionein I promoter-rat GH construct. These mice grew
at a faster rate to a final size 1.9-fold larger than non-transgenic controls. Since
then, size increases of 1.9-fold to 4.0-fold have been reported in mice
expressing transgenes for rat, human and ovine GH (see Brem at aI., 1989).
Pomp et al. (1992) reported increased growth as well as increased efficiency of
growth and lean tissue production in mice expressing a sheep metallothionein
1a-sheep GH transgene.
The introduction of a fusion gene containing human GH linked to a murine
metallothionein promoter into transgenic rabbits, sheep and pigs was reported
by Hammer et al. (1985). None of these animals grew at increased rates despite
expression of the hGH transgene. Out of six transgenic pigs, Vize et al. (1988)
reported one pig with increased growth due to the expression of a human
metallothionein-IIA-porcine GH gene construct.
Pursel et al. (1989) studied the long term effects of elevated plasma GH
levels in two lines of pigs expressing a bGH transgene. Two successive
generations displayed significant improvements in daily weight gain and feed
efficiency, and exhibited changes in carcass composition including a marked
reduction in subcutaneous fat. However, the long term elevation of bGH was
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detrimental to the health of the pigs as they demonstrated increased incidences
of gastric ulcers, arthritis, cardiomegaly, dermatitis, and renal disease. The
authors concluded that better control of the transgene, a different genetic
background, or a modified husbandry regimen would be necessary in order to
gain the beneficial, growth-promoting effects of elevated GH without a damaging
decline in health and fitness of the animals (Pursel et at, 1989).
Pituitary Transcriptional Activator Pit-1
Required for GH and Prolactin Synthesis. Bodner and Karin (1987) first
identified the pituitary cell-type specific factor GHF-1 as a transcription factor
necessary for the expression of GH. GHF-1 was shown to bind to the promoter
of the hGH gene at two sites upstream of the hGH TATA box. Binding of GHF-1
to both sites was necessary for maximal expression of hGH, suggesting that an
interaction between GHF-1 molecules was required for optimal stimulation of
transcription.
Nelson et al. (1988) used competition experiments to show that a single
transcription factor was capable of activating both GH and Prolactin (PRL)
genes. A comparison of the sequences of GH and PRL promoter elements and
their binding affinities revealed a consensus sequence with a core of TATNCAT
in both genes. The authors suggested that a common pituitary transcriptional
activator, termed pituitary transcriptional activator-1 (Pit-1), recognized the
consensus sequence and allowed the expression of GH and PRL by anterior
pituitary somatotroph and lactotroph cells, respectively.
Conflicting results were observed by Castrillo at at (1989). GHF-1 was
purified from extracts of GH and PRL-expressing pituitary tumor cells and
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identified as a 33 kilodalton polypeptide. DNase I footprinting experiments
showed significant binding of GHF-1 to the GH promoter, but failed to show
binding of GHF-1 to the PRL promoter. In contrast to the conclusions made by
Nelson at al. (1988), Castrillo et al. (1989) suggested that two separate factors
control the expression of GH and PRL genes.
The cDNA sequences of GHF-1 and Pit-1 were independently determined
by Bodner et al. (1988) and Ingraham et al. (1988), respectively. Bodner et al.
(1988) purified the GHF-1 protein to near homogeneity and determined a partial
amino acid sequence. Complete cDNA sequences for the coding regions of
bovine and rat GHF-1 were derived from eDNA libraries screened with synthetic
oligonucleotide probes corresponding to the partial GHF-1 amino acid
sequence. Ingraham et al. (1988) sequenced DNA complementary to Pit-1
mRNA, cloned on the basis of specific binding to AT-rich cell-specific elements
in the rat PRL and GH genes. The cDNA sequences for GHF-1 and Pit-1 were
identical. In accordance with recent literature, this pituitary specific transcription
factor will hereby be referred to as Pit-1.
Homeobox-containing Protein. The Pit-1 eDNA sequence included an
873 nucleotide open reading frame encoding a 291 amino acid protein with a
predicted molecular weight of 32.9 kilodalton (Ingraham at at. 1988). Identity
between amino acid sequences predicted by rat and bovine eDNA's was 93°A»
(Bodner et aI., 1988). Comparison of the Pit-1 amino acid sequence with other
known DNA binding proteins revealed a 60 amino acid sequence at the carboxyl
terminus of Pit-1 that exhibited statistically significant similarity with several
homeobox-containing proteins (Bodner at al.. 1988; Ingraham at aI., 1988).
Homeobox-containing proteins have been identified as important gene
regulators in Drosophila. and sequences homologous to the homeobox have
been isolated from higher organisms (Gehring, 1987). The homeobox domain
13
encoded by homeotic genes mediates binding to specific DNA sequences. This
allows the homeotic proteins to have a gene regulatory function which has been
shown to specify the identity and spatial arrangement of body segments in
Drosophila (Gehring, 1987).
The greatest similarity between Pit-1 and other homeobox-containing
genes was found at the C-terminal one-third of the homeobox, which is the most
highly conserved region among all known homeoboxes (Gehring, 1987). The
entire Pit-1 homeobox displayed 73% identity with a homeobox consensus
sequence derived from a large number of homeoboxes from different species
(Bodner et aI., 1988). This identity increased to 78% if conservative amino -acid
changes were taken into consideration. No significant similarities between Pit-1
and other homeobox-containing proteins were observed outside the homeobox
domain (Bodner et aI., 1988; Ingraham at aI., 1988).
Member of the POU-domain Family. Pit-1 was further characterized as a
member of the POU-domain family of genes, which was originally named for
sequence similarity among the three mammalian proteins Pit-1, Oct-1 and Oct-2
and in the product of the unc-86 gene of the nematode Caenorhabditis elegans
by Herr et al. (1988). The POU-domain is a 150- to 160-amino-acid long region
comprised of two conserved subdomains (Herr et aI., 1988; Rosenfeld, 1991);
the POU-specific (POUS) subdomain and the homeobox-related (POUHD)
subdomain previously described (Bodner et aI., 1988; Ingraham et aI., 1988).
The POUS subdomain is the region that most strongly characterizes the POU
proteins as a distinct class and may have been conserved by functional
constraints on the protein products (Herr at aI., 1988). Unlike the homeobox-
containing proteins which interact with DNA at only one location, POU-domain
proteins contact DNA recognition sites at two locations, the POUHD and the
POUS domains. Rosenfeld (1991) suggested that the POUS domain interacts
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with the sequence motif TATNCA while the POUHD domain interacts with AIT
rich sequences 5' of the TATNCA core of target DNA sequences. Both
subdomains are required to permit high-affinity. site specific binding of POU
proteins to their target DNA sequences (Rosenfeld, 1991). POU-domain
proteins have also been implicated in early developmental regulation of gene
transcription, the proliferation of specific cell types, progression and commitment
events in organogenesis, and the stimulation of DNA replication (Rosenfeld,
1991 ).
Involvement in Expression of Other Genes. Expression of Pit-1 was
originally thought to be limited to GH-secreting (somatotroph) and PRL-secreting
(Iactotroph) cells of the anterior pituitary (Bodner et al.. 1988; Ingraham at aI.,
1988). Simmons at al. (1990) demonstrated that Pit-1 is also expressed in
thyrotropin (TSH)-secreting cells (thyrotrophs). In contrast to the requirement of
Pit-1 before GH and PRL expression by somatotrophs and lactotrophs,
expression of TSH precedes expression of Pit-1 in thyrotrophs (Simmons at aI.,
1990). Steinfelder at al. (1992) provided evidence that Pit-1 is involved in the
regulation of TSH expression by mediating thyroliberin (TRH) and cAMP
stimulation of the TSH~ gene. The mechanism that allows Pit-1 regulation
involves phosphorylation of Pit-1 for increased binding of Pit-1 to at least two Pit-
1 binding sites in the TSH~ gene. Binding of phosphorylated Pit-1 allows for
hormonal responsiveness to TRH and cAMP and increased expression of the
TSH~ gene (Steinfelder at aI., 1992).
Pit-1 has also been implicated in the expression of the receptor for GRF
(Lin at al., 1992). GRF receptor transcripts were first detected two days after the
first detection of Pit-1 transcripts, and were found only in tissues known to
express Pit-1. GRF receptor transcripts were not detected in a line of dw/dw
dwarf mice known to lack Pit-1. Lin et al. (1992) suggested that pituitary
IS
hypoplasia observed in dw/dw mice was due in part to the absence of GRF
receptor which was caused by a lack of functional Pit-1.
Mutations and Polymorphisms in the Pit-1 Gene. Several reports of
mutations in the Pit-1 gene have resulted in combined pituitary hormone
deficiencies. Homozygosity for a nonsense mutation in the Pit-1 gene caused
cretinism along with hormone deficiencies of thyrotropin, GH. and PRL in
humans (Tatsumi et aI., 1992b). Three different Pit-1 point mutations were
identified in the transactivation region, POUS and POUHD domains of three
children with combined pituitary hormone deficiencies (Ohta et at, 1992). Pfaffle
at al. (1992) reported a mutation in the POUS domain of the Pit-1 gene which
resulted in a protein capable of binding DNA response elements but unable to
activate target genes, resulting in deficiencies of GH. PRL. and TSH. The
mutant Pit-1 was capable of initiating other programs of gene activation required
for the normal proliferation of somatotroph, lactotroph and thyrotroph cells. A
different mutation in the POUHD domain of Pit-1 identified by Radovick at al.
(1992) produced a mutant protein that would bind DNA normally, but inhibited
Pit-1 action in the pituitary of two strains of dwarf mice. resulting in hypoplasia of
GH, PRL. and TSH secreting cells.
The Pit-1 gene has also been investigated for use as a genetic marker in
livestock species. Tuggle et al. (1993) used a partial Pit-1 POU-domain eDNA
probe to screen for RFLPs in different breeds of swine. Polymorphic BamHI
fragments were found in the Chinese breed Meishan. but no polymorphisms
were identified in five American breeds of swine. Polymorphic Mspl bands were
reported by Yu et al. (1993) in the Chinese breeds Fengjing. Meishan and
Minzhu as well as the American Yorkshire breed using the same Pit-1 probe as
described by Tuggle et al. (1993).
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Growth Hormone Receptor
Identification. In order for GH to produce a biological response, it must
bind with a receptor at a target tissue. There are at least three distinct but
related families of receptors which bind GH and/or the structurally related
hormones PRL and placental lactogen (PL) to carry out a physiological response
(Roupas and Herington, 1989). These receptors may be identified as the
somatotrophic receptor, the lactogenic receptor and the PL receptor. This
review will focus on the somatotrophic receptor (GHR) because of its
physiological effects on growth and metabolism.
GHR has been identified in a variety of tissues including adipose, heart,
kidney, liver, fibroblasts, lymphocytes, muscle and ovary (see Roupas and
Herrington, 1989). GHR has also been identified on human growth plate
chondrocytes (Werther et aI., 1990), and Glimm et al. (1990) provided evidence
for the expression of GHR by lactating mammary tissue. GHR appears to be
highly conserved across species with 84°k amino acid identity observed between
rabbit and human GHR amino acid sequences (Leung at al., 1987), and 70-80%
amino acid similarty in bovine GHR compared to human, rabbit, mouse and rat
GHR (Hauser at aI., 1990). GHR contains distinct extracellular, transmembrane
and intracellular components and is not similar in amino acid sequence to
previously sequenced proteins, suggesting that GHR belongs to a unique family
of transmembrane receptors (Leung et al., 1987).
GHR gene. Amino acid and nucleotide sequences have been determined
for GHR mRNA in bovine (Hauser at aI., 1990), ovine (Adams et aI., 1990) and
rat (Mathews et at, 1989). The complete human GHR gene has been described
by Godowski et al. (1989). The human gene for GHR spans at least 87-kb
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(Barton et at, 1989). Nine exons (numbered 2-10) encode the coding and 3'
untranslated regions of the gene. Exons 2-9 range in size from 66 to 179 bp,
whi~e exon 10 is approximately 3400 bp. The putative secretion signal sequence
for human GHR is encoded by exon 2; exons 3 to 7 are translated to the
extracellular GH binding region; axon 8 encodes the transmembrane domain;
and exons 9 and 10 encode the cytoplasmic domain and 3' untranslated region
(Godowski at aI., 1989). Abnormal GHR genes have been identified in human
patients with Laron-type dwarfism (Godowski et al., 1989; Berg at aI., 1993) and
in chickens with sex-linked dwarfism (Burnside at aI., 1992). The GHR gene has
been mapped to human chromosome 5p14-p12 (Davisson et aI., 1991) and,
chromosome 16 in pigs (Chowdhary at aI., 1994).
Regulation of GHR Expression. Regulation of hormone receptors is an
important regulator of hormone action. The regulation of GHR expression has
been studied in a variety of species and tissues with many conflicting results.
Stage of development, level of nutrition, insulin and GH itself all appear to have
an effect on the regulation of GHR.
Mathews et al. (1989) reported developmental regulation of GHR in rat
liver, kidney, heart and muscle tissue. Expression of GHR was significantly
lower at birth than in adults. Expression increased through neo-natal
development to reach a maximum at 5 to 8 weeks after birth for liver, kidney and
heart tissues, while increased expression continued through post-pubertal
development for muscle tissue. No significant differences in liver GHR were
observed between male and female rats, although higher levels of GHR were
observed in the livers of pregnant females. Earlier studies reviewed by Roupas
and Herington (1989) cited similar evidence for developmental regulation of
hepatic GHR, as well as a lack of difference between male and female rat
adipocyte GHR. However, other studies cited in the same review reported
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increased hepatic GHR in females compared to males for both mice and rats.
Developmental regulation of GHR in rabbits indicates an increase in hepatic
GHR during puberty with additional increase of GHR during pregnancy. but no
sex differences observed for hepatic GHR binding. In contrast, ovine livers did
not show an increase in GHR during the latter part of gestation (see Roupas and
Herrington, 1989).
Nutritional status has been implicated in the regulation of GHR. Hepatic
GHR capacity decreases during fasting in rats, and is restored upon refeeding
(Baxter at aI., 1981; Maas et ai, 1983; Postel-Vinay at aI., 1982). Breier et al.
(1988a) examined the effects of low and high planes of nutrition on the presence
of GHR in steers. It was observed that high-affinity GHR were present in steers
on the high plane of nutrition, but not in steers on the low plane of nutrition. In
steers fed for a high plane of nutrition, weight-gain was proportional to the high-
affinity GHR, and a single injection of bGH produced an increase in circulating
IGF-1 concentrations (Breier et aI., 1988b), confirming the biological function of
the high-affinity GHR.
Insulin has been implicated in the control of GHR, although its role has
not been well defined. A decrease in insulin has been shown to result in
decreased liver GHR in rats with chronic renal insufficiency (normal circulating
GH and PRL, but decreased insulin; Finidori et aI., 1980); and in rats with
hypoinsulinemia due to fasting (Baxter at al.. 1981). Baxter at al. (1980) showed
that the loss of rat hepatic GHR that occurs during fasting may be reversed by
insulin.
GH is involved in the regulation of its own receptor, but studies have
presented conflicting observations concerning this regulation. Many of these
studies were reviewed by Roupas and Herington (1989) and are summarized in
Table 5. Roupas and Herington (1989) suggested that GH has a long-term role
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in the maintenance of GHR, but recommended using caution to interpret
observations of acute down-regulation by GH because of the irreversible binding
of GH to GHR proposed by Donner et al. (1978) and Gorin et al. (1984), and the
complex pathways involved in GHR turnover. More recently, Mullis et al. (1991)
and Nilsson at al. (1990) both provided evidence for the regulation of GHR
mRNA expression by direct actions of GH on human hepatoma cells and rat
epiphyseal chondrocytes, respectively. Both conclude that the physiological
significance of a rapid increase in GHR gene expression is difficult to determine
due to the complexity of the regulation. This complexity is increased by the
physiological pulsatile release of GH, and the elusive role of GH binding protein
(Nilsson et aI., 1990).
Table 5. Summary of observations of GH regulation of GHRa.
Tissue GH treatment Effect on GHR
GHR decreased
Normal GHR

















rGH infusion in vivo
GH infusion in vivo
Cultured human
IM-9 lymphocytes
Mouse fibroblast GH treatment GHR decreased








aReferences presented in review by Roupas and Herington (1989).
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Fate of GHR. Little is known about the turnover and degradation of GHR.
Several studies have observed rapid turnover rates for GHR with t112 values
ranging from 45 minutes in adipocytes to 8 hours in human IM-9 lymphocytes
(see Roupas and Herington, 1989). This turnover rate is much more rapid than
the turnover rates observed for insulin and epidermal growth factor (EGF)
receptors. but it is similar to turnover rates observed for PRL (see Roupas and
Herington, 1989). GH and PRL differ from insulin and EGF in that GH and PRL
are both secreted in a pulsatile manner. Baxter (1985) suggested that a rapid
turnover rate of receptors would be necessary in order for receptors to recognize
individual pulses of hormones and to allow pulse-related responses to occur,
assuming hormone action is mediated or terminated by internalization and
degradation of occupied receptors. Roupas and Herington (1988) showed that
the turnover rate of GHR in cultured adipocytes was more rapid in the presence
of GH, suggesting that receptor occupancy leads to a shorter half life.
The fate of GHR following GH binding remains unclear. Roupas and
Herington (1989) suggest a model for GHR degradation whereby the turnover of
GHR is rapid and constitutive with the turnover rate increasing in the presence
of GH. Although evidence has not been reported, it is assumed that degradation
occurs via classical mechanisms of cell surface redistribution and
microaggregation in coated pits. Because GH does not disassociate from GHR
at the pH of pre-lysosomal endosomes (Mellman et aI., 1986), Roupas and
Herington (1989) suggest the fate of GH and GHR are the same on a
degradative pathway.
GH Binding Proteins. Serum proteins which specifically bind human GH
have been identified by Ymer and Herrington (1985) and Baumann et at (1986).
Leung et al. (1987) and Spencer et al. (1988) demonstrated in rabbits that the
amino terminal amino-acid sequences of GH binding protein (GHBP) and GHR
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are identical, establishing the serum binding protein as the extracellular
hormone-binding domain of the membrane bound receptor. Leung at al. (1987)
originally suggested that GHBP may be formed by proteolytic cleavage of the
binding domain of GHR. Baumbach at al. (1989) has since shown in rats that
GHBP is formed by a mechanism of alternative splicing of the GHR gene. Laron
dwarfs, which have normal circulating GH concentrations but low IGF-I
concentrations, are thought to lack functional GHR. It has been shown that they
have little or no GHBP activity (Baumann at aI., 1987; Daughaday and Trivedi,
1987), which is consistent with the structural origin of GHBP.
GHBP slows the clearance rate of bound GH (Baumann et aI., 1987) and
may serve as a circulating reservoir and buffer for GH. GHBP inhibits GH
binding to receptors and bioactivity in vitro, but can enhance GH bioactivity in
vivo. This discrepency may be due to the extended half-life of bound GH in vivc
(see Baumann at aI., 1991).
Davis et al. (1992) reported the presence of a protein which specifically
bound GH in ovine, bovine, chicken, human, goose, porcine and equine serum.
Chicken, ovine and porcine GHBP were purified and showed higher binding
affinity for human GH as compared to GH from the same species. Binding
affinities for ovine placental lactogen and ovine GH were intermediate between
the affinities of human GH and GH from the same species in chicken and swine
Variation in binding affinities was observed within and between species with the
highest affinity observed in porcine and lowest in Qvine. Davis at al. (1992)
concluded that even though GHBP does not bind GH as strongly in many
domestic species as compared to humans, the functional significance of GHBP
in domestic species cannot be disregarded without further investigation.
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Insulin-like Growth Factors
Identification. Two insulin-like growth factors, IGF-I and IGF-II, have been
purified from plasma and share roughly 40% amino acid identity with insulin
(Rinderknecht and Humbel, 1978a,b). IGF-II is present in high concentrations
in fetal plasma and tissues, but concentrations decline rapidly postnatally
(DeChiara et aI., 1991). Postnatally, IGF-I mediates many of the growth-
promoting effects of GH. Other biological effects of IGF-I include: acting as an
insulin mimic; stimulating cell differentiation; and stimulating renal Na transport
(Etherton and Smith, 1991). IGF-I is a 70 amino acid, single-chain protein with 'a
calculated molecular weight of 7500 Da. IGF-I is highly conserved among pigs,
cattle, and sheep (Etherton and Smith, 1991), and is identical at 67 of 70 amino
acid residues between rat and human (Shimatsu and Rotwein, 1987). IGF-I
displays obvious homology with proinsulin, and its amino acid sequence is
compatible for a conserved 3-dimensional structure with insulin (Rinderknecht
and Humbel, 1978a).
IGF-I Gene. The IGF-I gene has been isolated and characterized in the
human (Rotwein et aI., 1986), rat (Shimatsu and Rotwein, 1987) and ovine
(Dickson at aI., 1991). The gene for IGF-I is large, spanning at least 45 kb in
human (Rotwein et aI., 1986) and 73 kb in ra1 (Shimatsu and Rotwein, 1987). It
is organized in 5 exons and 4 introns, and is expressed as multiple mRNA
species in human and rat (Rotwein et al., 1986; Shimatsu and Rotwein, 1987).
Rotwein et al. (1986) identified an RFLP near axon 5 of the human IGF-I
gene using the restriction enzymes Hindlll and Pvull. Kirkpatrick (1992b)
described a microsatellite polymorphism in the IGF-I gene in bovine and porcine.
Six alleles of IGF-I were observed in porcine, and 3 alleles were observed in
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bovine (Kirkpatrick, 1992b). Bishop et al. (1991) identified an RFLP in Polled
Hereford and Angus cattle from genomic DNA digested with Pvull and Pstl
restriction endonucleases.
Expression of IGF-I. Although IGF-I is produced primarily in the liver,
D'Ercole at al. (1984) provided evidence that IGF-I is also produced locally by
several tissues. By extracting IGF-I from tissues of hypophysectomized rats, it
was shown that IGF-I concentrations from kidney, lung, heart, testis and liver
increased following GH treatment. This provides support for an
autocrine/paracrine mechanism of action for IGF-I produced locally in mUltiple
tissues. This is in contrast to previous thought that IGF-I acted by an endocrine
mechanism. D'Ercole et al. (1984) observed that at maximal response to GH,
mean tissue IGF-I levels were higher than IGF-I concentration in whole blood,
suggesting that IGF-I produced from multiple tissues determines serum IGF-I
concentrations. Further evidence for local control of IGF-I production by GH was
provided by Isgaard at al. (1988). These researchers found that GH treatment
caused an increase in IGF-I mRNA in rib growth plate and liver of
hypophysectomized rats. The increase in IGF-I mRNA observed in the rib
growth plate was caused, in part, by an increase in the rate of transcription of
the IGF-I gene in chondrocytes, and the IGF-I gene was specifically activated.
Mathews at al. (1988b) describe the overespression of human IGF-I
(hIGF-I) in mice carrying a hIGF-I-mouse metallothionein promoter. Increased
levels of hIGF-1 were found in liver, pancreas, lung, kidney and brain of
transgenic mice compared to non-transgenic controls. Mice expressing the
hIGF-1 transgene displayed plasma IGF-I levels 1.5 x normal levels, and grew to
weights of 1.3 x the weights of non-transgenic controls. However, the increase
in weight was not apparent until 6 weeks after birth and resulted from selective
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organomegaly without an increase of skeletal size. In addition, expression of
endogenous IGF-I and GH was inhibited by expression of the hIGF-1 transgene.
Plasma levels of IGF-I were studied in mice with the high growth
recessive mutation gene (hg) in lines which had been selected for growth (G)
and in non-selected lines (C; Medrano et aI., 1991). C and G lines without the
hg mutation were studied as controls for each genetic background. Mice with
the hg gene had significatly higher plasma IGF-I levels compared to controls at
3,4.5 and 9 weeks of age in the C lines, and at 6 weeks of age in the G line.
This study also considered plasma and pituitary GH levels and reported a
significant decrease in GH levels in mice with the hg gene compared to controls.
These results are consistent with results reported by Mathews at al. (1988b)
from transgenic mice engineered to overproduce human IGF-1. These
similarities suggest that elevated IGF-Ilevels in hg mice may be a direct result of
the hg mutation due to a molecular alteration of the IGF-I gene. Observations of
decreased plasma and pituitary GH from both studies also implicate IGF-I as a
regulator of GH expression through a negative feedback mechanism (see
Medrano et aI., 1991).
Chow et al. (1994) studied the regulation of IGF-I and binding protein-3
expression in transgenic mice carrying the metallothionein la-ovine growth
hormone (oMtla-oGH) transgene. Expression of the transgene was activated or
inactivated by the addition or removal of 25 mM zinc sulfate in the drinking
water. Expression of the oMtla-oGH transgene significantly increased plasma
IGF-Ilevels, as well as hepatic IGF-I mRNA. However, the increase in hepatic
IGF-I mRNA accounted for only a portion of the observed increase of plasma
IGF-1. After a review of other studies considering the regulation of plasma IGF-I,
the authors concluded that oGH-induced post-transcriptional regulatory
mechanisms, production of IGF-I by other GH-responsive tissues, and elevated
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plasma IGF binding protein levels may account for the additional rise in plasma
IGF-Ilevels they observed in oMtia-oGH transgenic mice (see Chow at al.,
1994).
IGF-I Action. The GH mediating actions of IGF-I were originally thought
to be carried out by an endocrine mechanism, as suggested by the somatomedin
hypothesis. Recently, this has received considerable debate. Schlechter at al.
(1986) demonstrated that the direct growth promoting effects of GH on cartilage
are due, at least in part. to local production of somatomedins. They found that
direct infusion of both rGH and hIGF-1 at the epiphyseal cartilage plate in
hypophysectomized rats increased unilateral growth. However, the stimulatory
effect of hGH was abolished by simultaneous infusion of antiserum to IGF-1.
These results suggest that local somatomedin production may be important in
stimulating growth.
An autocrine/paracrine mechanism of IGF-I activity has been supported
by many studies. Kerr et al. (1990) failed to observe a decrease in growth of
guinea pigs treated with a monoclonal antibody to IGF-1. Because the antibody
bound and inactivated circulating IGF-I, they suggested that local production of
IGF-I was sufficient to maintain normal growth. Skottner et al. (1987) observed
little growth promoting action from administration of recombinant methionyl IGF'-I
(met-IGF-I) in hypophysectomized rats. Significant effects on body weight gain
were observed only when high doses of met-IGF-I were used. Because met-
IGF-I was shown to be biologically active in the hypophysectomized rat, the
authors concluded that it is a relatively poor growth promoting agent when given
systemically, and that somatomedins are more likely to act via an
autocrine/paracrine rather than endocrine mechanism. Similar results were
obtained by Skottner et al. (1989) in a study involving a mutant GH deficient
dwarf rat. High, but not low doses of IGF-I resulted in body weight gain similar
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to that observed after hGH treatment. However, IGF-I treatment resulted in
specific tissue growth of kidney, adrenal and spleen while hGH resulted in
greater bone growth. hGH treatment did not produce an increase in circulating
IGF, providing further evidence that GH action is not carried out by circulating
IGF alone.
Finally, in vitro studies have shown that IGF-I is capable of being
produced and acting locally to stimulate bone growth. Nilsson et at (1989)
demonstrated that the IGF-I gene is expressed in the rat epiphyseal growth plate
chondrocytes under the control of GH, and Scheven and Hamilton (1991)
reported IGF-I stimulated growth in vitro of rat intact long bones.
Although these studies do indicate an important role of locally produced
IGF-I, reports of significant effects of circulating IGF-I cannot be overlooked.
Schoenle et al. (1982) reported that pure IGF-I stimulated growth in a dose
dependent manner in in hypophysectomized rats. An increase in circulating
IGF-I was observed prior to increased growth in mice carrying GH or GRF fusion
genes (Mathews et aI., 1988a). Guier et al. (1988) found that infused
recombinant IGF-I and hGH caused similar increases in body weight, tibial
epiphyseal width, longitudinal bone growth and trabecular bone formation in
.hypophysectomized rats, although differences in organ weights were observed .
between the two treatments. Thus, there is evidence supporting the
somatomedin hypothesis with an endocrine function of IGF-I. However, this
evidence does not exclude the possibility that many effects of IGF-I are carried
out by locally produced IGF-I acting via an autocrine/paracrine mechanism. '
IGF-I Binding Proteins. In serum, almost all IGF-I is complexed to one of
several IGF binding proteins (IGFBP). There are at least 3 distinct classes of
IGFBP designated as IGFBP-1, 'IGFBP-2 and IGFBP-3 (see Etherton and Smith,
1991). As reviewed by Pell and Bates (1990), several theories regarding the
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function of IGFBP have been proposed. It has been suggested that the pool of
protein-bound serum IGFBP may act as a storage depot or a reservoir for IGF-I,
continuously releasing small amounts of IGF-I to bind to receptors. IGFBP have
been shown to both stimulate and inhibit IGF-I action. It is not clear if they have
both effects in vivo, and studies using IGFBP-I and IGFBP-3 have produced
conflicting results (see Etherton and Smith, 1991). Finally, it has been
suggested that the effect of GH on locally produced IGFBP, rather than the
effect of GH on IGF-I. is the important step in regulating IGF-I action in response
to GH (Etherton and Smith, 1991).
IGF-I Receptors. IGF-I will bind to three types of receptors: the insulin
receptor. and type 1 and type 2 growth factor receptors (Rosenfeld, 1989). Type
1 and type 2 IGF receptors are similar in amino acid sequence to the insulin
receptor. and the type 1 receptor has been shown to behave in a manner similar
to the insulin receptor (Furlanetto, 1988). However, the insulin receptor
modulates metabolic processes whereas the IGF-I receptor stimulates cell
proliferation and differentiation (Pell and Bates, 1990).
Genetic Control of Growth
Heritability of Growth Traits
Growth is a quantitative trait controlled by several genes that each
contribute a partial effect to the overall trait. Attempts have been made at
estimating the number of loci involved in controlling body weight in mice, but the
validity of these estimates is questionable because of their large range. As







0.27 0.14 0.29 Smith, 1989
0.51 0.30 0.36 Alenda. 1987
0.41 0.21 0.18 Alenda, 1987
0.37 0.49 Johnson, 1992
0.46 0.39 .040 Winder. 1990
0.28 0.19 0.17 Kriese, 1991
0.37 0.28 0.32 Average
the difficulty in determining the actual number of loci influencing quantitative
traits such as growth and body weight, these traits are almost certainly
controlled by many genes with small effects, as well as some genes with large
effects (Eisen, 1980).
Growth traits in beef cattle are generally considered to be moderately
heritable. Recently reported heritabilites for growth traits ranged from .10 to .58
for a variety of populations, with average heritabilities of .37, .28 and .32 for birth
weight, weaning weight and yearling weight, respectively. (See Table 6.)
Table 6. Summary of recent reports of heritabilites for growth traits.
Heritability Estimate
=--B_WT--=-__WWT YWT R_e_f_er_e_n_ce P_opulation
0.50 0.25 Nelsen, 1986 Hereford
0.39 0.34 Nelsen, 1986 Hereford
0.12 Lamb. 1990 Hereford
0.33 0.50 Kriese, 1991 Hereford
0.24 Reynolds, 1991 Hereford
0.58 Johnson. 1992 Hereford
0.17 Vaseth, 1993 Hereford









Heritability estimates indicate the portion of phenotypic variance
controlled by additive genetic variance. These estimates for growth traits
indicate that a substantial portion of observed phenotypic variation in growth is
controlled by additive genetic effects which will be passed from parent to
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offspring. Therefore, growth traits should respond well to selection pressure for
increased growth (Falconer. 1989).
Correlations Among Growth Traits
Correlations among growth traits are high. indicating that selection for
increased growth at one age will result in increased growth at other ages.
Recently reported correlations are summarized in Table 7.
Table 7. Genetic (above diagonal) and phenotypic (below diagonal) correlations
among growth traits.






Birth Weight .52(a) .58(a) .45(a)
.25(b) .41(b) .57(b)
.56(c) .57(c) .31 (c)
.57(d} .75(d) .61 (d)
Weaning .26(a) .80(a) .56(a)
Weight .31 (b) .84(b) .49{b)
.38(c) .78(c) .18(c)
.34(d) .89(d) .37(d)
Yearling .37{a) .68(a) .92(a)
Weight .35{b) .79(b) .84(b)
.39(c) .63(c) .75(c)
.37(d) .77(d) .90(d)
Average Daily .21 (a) .05(a) .68(a)




(a) Smith at al., 1989a
(b) Smith et at, 1989b
(c) Brinks at aI., 1990
(d) Alenda and Martin, 1987
30
Variation in Genetic Merit for Growth
Considerable variation in growth rate and weights at particular ages is
known to exist between and within breeds of cattle, as summarized by Cundiff at
al. (1986) in a review of the cattle Germ Plasm Evaluation Program at the
Roman L. Hruska U.S. Meat Animal Research Center. Performance data from
progeny of topcrosses by 20 sire breeds were used to estimate breed averages
for economically important traits, including growth. The range (R) between the
highest and lowest breed averages for growth traits along with phenotypic
standard deviations calculated within breed groups (ap) are presented in Table
8. This large amount of variation for growth traits increases the amount of
response that would be expected when selection pressures are placed on
growth traits (Falconer, 1989).
Table 8. Range (R) and phenotypic standard deviation (ap) within breed groups
from estimates of breed averages from the cattle Germ Plasm Evaluation
program.a
Trait Breed Groups R ap 2RIa
p
Birth weight, kg Maine Anjou, Charolais - Jersey 10 4.3 4.7
400-day weight, kg Gelbvieh - Jersey 25 20.0 2.5
Postwean gain, 9 Simmental - Red Poll, Sahiwal 222 117.0 3.8
(steers)
.424-day weight, kg Charolais, Simmental - Red Poll 73 36.0 4.1
(steers)
400-day weight, kg Maine Anjou - Jersey 55 27.0 4.1
(heifers)
aCundiff et aI., 1986
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Selection for Growth Traits
Beef Cattle. Selection for postweaning growth in Line 1 Hereford cattle
was described by MacNeil at al. (1992). The expected selection differential for
yearling weight, averaged over sexes, was 31.2 kg per generation. Correlated
responses of increased birth weight, preweaning ADG and postweaning ADG
were also observed. Breeding values of birth weight, weaning weight and
yearling weight increased by a total of 3.2 kg, 14.5 kg and 62.4 kg, respectively,
from 1935 to 1989. No selection plateaus have been observed after 13
generations of selection.
In comparison, data from calves produced over 21 years in a herd of
Angus cattle selected for increased yearling weight was studied by Alenda and
Martin (1987). A response of 15.18 kg per generation was calculated when
yearling weight was the selection criterion. Correlated increases in birth weight,
weaning weight, postweaning gain and post-birth gain were observed as a result
of selection for increased yearling weight.
Additional indications of response to selection for increased growth in
beef cattle may be found by examining field data reported to breed
organizations. Because most cattle are marketed on the basis of weight,
.selection for increased weights at particular ages has been practiced in the beef
industry for many years. Efficiency of this selection has been greatly increased
by the publication of sire evaluations, presented as expected progeny
differences (EPD). by breed organizations. Currently, 16 breeds sponsor sire
and breed evaluation programs (Ludwig, 1993). The 1993 Hereford Sire
Evaluation Report indicates that the Hereford breed has increased average birth
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weight, weaning weight, and yearling weight by 1.14. 14.93, and 24.24 kg.
respectively, from 1973 to 1992. These trends are shown in Figure 1.
Figure 1. Change. in pounds. of average birth weight. weaning weight, and
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Pigs. Increases in growth and growth rate resulting from selection have
also been well documented in pigs. Baird et al. (1952) reported two lines of
Hampshire pigs divergently selected for high or low 150-day weight diverged by
28.1 kg in 180-day weight after nine generations of selection. Rahnefeld (1973)
reported a realized heritability of .126 ± .029 in an experiment in which mass
selection for increased postweaning average daily gain had been practiced for
seven generations in Lacombe swine. A realized heritability of .198 ± .016 was
reported after 11 generations of selection in the same population (Rahnefeld
and Garnett, 1976). Mass selection for increased 70-day weight for six
generations in Landrace pigs was reported by Kuhlers and Jungst (1990). The
total weighted cummulative selection differential was 30.3 kg, representing 6.11
phenotypic standard deviations. Response per generation for 70-day weight
was reported as .65 ± .29 kg with a realized heritability of .13 ± .06. Woltmann
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et al. (1992) reported a difference in average daily gain of .16 kg from two lines
of pigs divergently selected for fast and slow growth for four generations.
Cumulative selection differentials of .335 and -.086 were observed in the fast
and slow lines, respectively.
Mice. Long term selection experiments for increased growth in laboratory
animals also demonstrate that growth and body weights can be significantly
altered as a result of selection (see Eisen, 1980). LaSal-le et at (1974) reported
an average increase in 21 to 42 day gain of .65 gram per generation in four
replicate lines of mice which had undergone mass selection for increased 21 to
42 day gain for 12 generations. Wilson et al. (1971) reported an increase in
average 60-day body weight of 18 Q, representing 7 phenotypic standard
deviation units, after 35 generations of selection in mice. Eisen (1972) observed
an increase in 12-day litter weight for 17 generations of selection in mice. Each
of these studies also reported selection limits after which no further increases in
body weights were observed.
Alternate Selection Criteria. Despite the economic advantages of
marketing animals with increased body weights, selection for increased weaning
or yearling weights alone can result in undesirable correlated responses in other
traits. Positive genetic and phenotypic correlations have been reported between -
calf birth weight and weaning and yearling weights (Smith at aI., 1989a,b; Brinks
et aI., 1990; Alenda and Martin, 1987), and calf birth weight is a major factor
contributing to dystocia and perinatal death loss in beef cattle (Laster et aI.,
1973). In addition, increased growth is often accompanied by increased mature
body size, fatness, and reduced fertility (Scholtz and Raux, 1984) which
increase the costs of beef cattle production. Therefore, there is considerable
interest in selecting cattle for increased growth and weights at particular ages
while limiting undesirable correlated responses in other traits.
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Arnold et al. (1990) selected Angus sires for either high birth weight and
high yearling weight EPD, or low birth weight and high yearling weight EPD in an
attempt to increase yearling weight without a correlated increase in birth weight.
Significant differences were observed in progeny for birth weight, but not for
weaning weight, post-weaning gain. or yearling weight. These results indicate
that the potential exists to increase genetic merit for growth to weaning and
yearling without significantly increasing birth weight.
Selection of Hereford bulls for rate and efficiency of gain was studied by
Mrode et al. (1990a,b). Bulls of two lines were selected for lean growth rate and
lean feed conversion ratio. Results after 8 years of selection indicated that
selection had been successful in both lines. with a greater response in the line
selected for lean growth rate. Correlated responses of increased body weights
were observed in males and females from the line selected for lean growth rate.
but only in females from the line selected for lean feed conversion ratio.
Correlated responses in lean proportion and food conversion ratio were found in
both selection lines, while no adverse correlations, such as calving difficulty. calf
mortality, or female reproductive performance. were observed in either line.
Environmental Effects. Another factor. besides genetics. that influences
growth rates in animals is the environment. Godfrey at al. (1990) studied the
effects of moving Hereford and Brahman bulls to different environments.
Hereford bulls from Montana and Nebraska that were relocated to Montana,
Nebraska, and Texas did not differ significantly in body wieght from controls
maintained in their original environment. with the exception of lower body
weights observed in bulls moved from Montana to Texas. In contrast, Brahman
bulls from Texas and Louisiana that were moved to Montana and Nebraska had
dramatically reduced body weights compared to control Brahman kept in Texas.
Relocated Brahman bulls also had smaller scrotal circumference and paired
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testis volume than controls. These results indicate that body and testis growth
of Brahman bulls were hindered by relocation to northern environments, but
comparable affects of relocation were not observed in Hereford bulls.
Butts et al. (1971) studied the possibility of genotype-environment
interaction in cattle within the Hereford breed. Two herds of Hereford cattle
originating from Montana and Florida were subdivided, and half of each
transferred to the opposite location. Significant location-origin interactions were
found for birth, weaning and yearling weights for both sexes. Performance to
yearling ages favored cattle raised in their native location. Significant
differences between location and between origin groups were found for several
traits measured. Results from this study gave support for the presence of
significant genotype-environment interactions in cattle within the same breed.
DeNise et al. (1988) and DeNise and Torabi (1989) studied the effects of
stressful environments on the estimates of genetic parameters for preweaning
and postweaning traits in Hereford cattle raised in the southwestern U.S.
Results indicated that genetic parameters change in response to the level of
environmental stress, and that the sexes respond differently to stressful
conditions. It was suggested that the genetic parameters differed because of
different genes affecting the traits of interest, or because of different relative
contributions of single genes that depended on the environment.
Summary
Experimental evidence shows that growth and body weights can be
influenced by selection. Growth traits are moderately heritable, and growth traits
at different stages of develpment are highly correlated. Because of the
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economic advantage of marketing animals at heavier weights, beef cattle
producers have practiced selection for increased growth rates. However, there
are limits due to increased cost of production and increased calving difficulty
which often accompany intense selection for increased growth. Recent studies
looking at alternative selection criteria have shown that genetic variation exists
to allow for continued imporovement in growth without detrimental correlated
responses in other traits. Finally, environment is important to the expression of
genetic potential for growth traits and should not be overlooked.
Genetic Markers and Marker Assisted Selection
Genetic Markers
The idea of Marker Assisted Selection was first presented by Sax (1923).
He suggested that if certain size factors, or genes for quantitative traits, could be
identified that were linked to genes for qualitative traits, then it should be
possible to study independently the genes for quantitative traits within each
linkage group marked by a qualitative trait. Thoday (1961) expanded on this
idea by describing the study of quantitative genetic differences using
-chromosomal markers. However, experimentation at that time was limited by the
lack of availability of useful genetic markers.
Beckmann and Soller (1983) described a new type of marker known as a
restriction fragment length polymorphism (RFLP). Unlike morphological or
pigmentation markers previously used in plants, or isozymes used in animals,
RFLPs are numerous and display important genetic traits such as a lack of
dominance and multiple allelic forms (Beckmann and Soller, 1983). In addition,
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RFLPs are located throughout the genome and provide a mechanism by which
complete genome linkage maps may be constructed (Botstein at aI., 1980).
RFLPs are identified by extracting genomic DNA, digesting the DNA with a
restriction enzyme and separating the resulting fragments using gel
electrophoresis. The separated fragments are then transferred to a membrane
using southern hybridization (Southern, 1975), and specific fragments are
identified by a labelled probe which is complementary in DNA sequence to the
genomic fragment of interest. Polymorphisms result when probes hybridize to
fragments differing in size because of changes in restriction enzyme recognition
sites, or insertions or deletions of DNA between restriction enzyme recognition
sites (Beckmann and Soller, 1983).
The development of the polymerase chain reaction (PCR; Saiki at aI.,
1985) has allowed for an alternative method to detect RFLPs known as PCR-
based RFLP or PCR-RFLP. This method involves the amplification of a specific
portion of genomic DNA using PCR. The resulting amplification product may
contain a polymorphic restriction enzyme recognition site. The polymorphism is
detected by digesting PCR amplification products with appropriate restriction
enzymes and then observing differences in the size of resulting digestion
fragments using gel electrophoresis. Some of the earliest bovine PCR-RFLPs
were reported by Medrano and Aguillar-Cordova (1990a, b) in genes for milk
proteins.
PCR has also been useful in developing another type of genetic marker
known as a microsatellite marker. Microsatellites are regions of tandem repeats
of di- or trinucleotide sequences in the genome (Tautz, 1989). Polymorphisms
result from different numbers of tandemly repeating units among different alleles.
Polymorphisms may be detected using PCR to amplify across a microsatellite
region and then determining which allele is present based on the size of the
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amplification product. Microsatellite polymorphisms have been found to be
highly polymorphic in all mammals, and are thought to be dispersed frequently
throughout the genome (Weber and May, 1989; Georges et aI., 1990; Love et
at, 1990; Cornall at at, 1991; Fries at at, 1990).
Another type of genetic marker is a single-strand conformation
polymorphism (SSCP). Orita et al. (1989) first described this type of
polymorphism using genomic DNA which had been digested with restriction
endonucleases. Single-stranded DNA fragments were electrophoresed on
neutral polyacrylamide gels. Mobility shifts representing single base
substitutions were observed in the single-stranded DNA fragments, possibly
resulting from conformational changes in the DNA. This technique has also
been successful in identifying polymorphisms in PCR amplification products
(Hayashi, 1992).
Genetic Maps
Techniques from molecular biology have allowed large numbers of useful
genetic markers to be identified in many species. In order to discern how these
markers can be helpful to livestock production, markers which are closely linked
to genes controlling quantitative traits of economic importance, or quantitative
trait loci (QTL), must be identified. Until recently, one of the limitations to
identifying markers linked to QTL in livestock species has been the lack of a
genetic linkage map (Dentine, 1992). A sufficient number of highly polymorphic
marker loci which are evenly distributed along the chromosomes is a
prerequisite for mapping QTL (Fries, 1993). The minimum number of markers to
39
cover the bovine genome at a spacing of 40 eM is estimated at 100, assuming
even distribution of crossovers along the chromosomes (Fries, 1993).
Recently, genetic linkage maps have been published for bovine
(Barendse at aI., 1994; Bishop at aI., 1994), porcine (Rohrer et aI., 1994) and
ovine (Crawford et aI., 1994). The bovine map described by Barendse et al.
(1994) includes 201 loci that were genotyped across cattle reference families.
These markers cover approximately 90% of the expected length of the cattle
genome and include 35 linkage groups representing 29 of the 30 pairs of
chromosomes. In comparison, the map described by Bishop et al. (1994)
includes 30 linkage groups represented by 313 genetic markers distributed on
24 autosomal chromosomes, the X and Y chromosomes, 4 unanchored syntenic
groups and 2 unassigned linkage groups. These maps provide the skeletal
framework upon which more detailed genome maps may be built, and may be
used in studies designed to investigate the genetic basis for quantitative traits
(Barendse et aI., 1994; Bishop at aI., 1994).
The development of gene maps in numerous species provide a valuable
resource for genetic analysis, as well as insight into the evolution of genome
organization by comparing linkage relationships of homologous genes (O'Brien
et, aI., 1993a). Comparative gene mapping involves the study of linkage
associations between homologous genes of different species and considers
persistent conservation of linkage order as evidence of functional or adaptive
significance (O'Brien et aI., 1993a). Comparative gene mapping has provided
evidence for the evolutionary origin of human chromosome 21 (Threadgill at aI.,
1991), and has revealed several conserved gene clusters including the Hox,
.MHC, immunoglobulin and globin clusters (Farr and Goodfellow, 1992).
Reviews comparing genomes among human, mouse, cattle, sheep, pig, rabbit,
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rat, hamster, horse, mink, silver fox and dog have been compiled (O'Brien et aI.,
1993 a,b).
Genetic Markers and Major Genes
Most traits of economic importance in livestock production are quantitative
or polygenic traits, implying that variation in the trait is determined by the action
of alleles at several loci, together with environmental factors. However,
examples of single genes which have major effects on the physiology and
economics of livestock production can be found. In these situations, genetic
markers resulting from mutations in the major gene, or genetic markers closely
linked to the major gene are useful in selection programs designed to control the
effects of the major gene.
In swine. pigs with the disease malignant hypothermia (MH) are more
susceptible to stress and are more likely to produce pale, soft and exudative
pork than normal pigs (O'Brien,1987). It has been thought that heterozygous
carriers of MH produce a net economic advantage over MH free pigs due to an
increase in lean yield (Simpson and Webb, 1989). However, more recent
studies using more accurate tests for MH heterozygosity have failed to show an
advantage of the heterozygous genotype (Webb et aI., 1994; Goodwin et aI.,
1994). Malignant hypothermia can be induced in living pigs using halothane
anesthesia to detect homozygous carriers of MH (Webb and Jordan, 1978), but
susceptibility to halothane anesthesia is controlled by a recessive gene (Hal)
and progeny testing has been required to identify heterozygous carriers. Fuji et
al. (1991) identified a C to T transition in the ryanodine receptor (also known as
the calcium release channel) gene that was detectable as a PCR-RFLP. This
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mutation was subsequently identified as the mutation responsible for MH in
swine (Houde at at, 1993; Otsu at aI., 1991). This PCR-RFLP is currently being
used by commercial swine companies to identify MH carriers and control the
disease in swine populations.
In horses, hyperkalaemic periodic paralysis (HVPP) results in potassium-
induced episodes of paralysis (Spier et aL, 1990). A C to G transversion was
identified in the sodium channel a subunit gene, resulting in a predicted
phenylalanine to leucine amino acid substitution (Rudolph at at. 1992). In an
HYPP quarter horse extended pedigree, all affected animals had the leucine
substitution while all unaffected animals demonstrated the phenylalanine
residue, indicating the sodium channel a subunit is a likely candidate gene for
HYPP. The C to G transversion may be detected by Taql restriction enzyme
analysis of PCR-amplified genomic DNA (Rudolph et al.. 1992).
Progressive degenerative myeloencephalopathy (weaver disease) is a
genetic disease common in Brown Swiss cattle. The microsatellite locus
TGLA116 was found to be closely linked to the weaver locus and may be useful
to select against the genetic disease (Georges at al.. 1993). Hoeschele and
Meinert (1990) reported that weaver-carrier cows produced significantly more
milk and more milk fat compared to weaver-free contemporaries. Therefore, the
TGLA116 marker may also be useful to study its chromosomal region as a
potential QTL for milk production (Georges et aI., 1993).
Bovine leukocyte adhesion deficiency (BLAD) is an autosomal recessive
genetic disease that has been characterized in Holstein cattle (Kehrli et al..
1990). Cattle homozygous for the disease have low resistance to infection and
usually die within a few months of birth. A PCR-RFLP reported by Shuster et al.
(1992) identifies a point mutation within the bovine gene encoding the adhesion
protein CD18. The point mutation results in an amino acid substitution in a
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region of the protein which has been shown to cause leUkocyte adhesion
deficiency in humans.
In sheep, Bcoroola ewes possess a major gene, FecS, that influences
their ovulation rate (see Bindon, 1984). Homozygotes (BB), heterozygotes (8+)
and non-carriers (++) of the FecS gene are identified on the basis of ovulation
rate recordings of ~5, 3 or 4 and 1 or 2, respectively (Davis et al.. 1982).
Montgomery et al. (1993) reported linkage between the FecS mutation and two
microsatellite markers (OarAE101 and OarHH55) and epidermal growth factor
from human chromosome 4q25. Lanneluc at al. (1994) also reported a cluster of
seven minisatellite fragments as being linked to the FecS gene. Linkage of a
genetic marker to the FecS gene could be useful in selecting sheep for
increased prolificacy.
A final example of important effects from a major gene can be found in
sheep where a mutation causing extreme muscle hypertrophy has recently been
identified. Muggli-Cockett at al. (1993) reported a variable number of tandem
repeat marker with five codominant alleles that was linked to the gene causing
muscle hypertrophy, which has been named callipyge. The callipyge locus has
since been mapped to Qvine chromosome 18 (Cockett et aI., 1994).
Genetic Markers and QTL: Candidate Gene Approach
In order for genetic markers to be useful in livestock production to assist
in selection of quantitative traits, genetic markers which are closely linked to
genes controlling quantitative traits. or quantitative trait loci (QTL), must be
identified. One approach to identifying such markers is known as the candidate
gene approach. Genes encoding proteins known to have important
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physiological effects on the trait of interest are identified as candidate genes.
Polymorphisms within these genes are then evaluated to determine if the
candidate genes are closely linked to a QTL, or if the candidate genes
themselves are involved in regulation of the trait of interest. Several examples
of possible linkages between genetic markers and QTL have been reported as a
result of this approach.
Rothschild et al. (1994) identified a polymorphism in the estrogen
receptor gene having a major effect on litter size in pigs. Rocha at at. (1992)
identified a significant effect of a GH-Taql allele on birth weight as a maternal
trait, and on shoulder width at birth in a five-breed diallel cross of beef cattle. A
significant effect was also found between a parathyroid-Mspl marker and
measures of body size in the same study. Hoj at al. (1992) observed different
allele frequencies for GH-Mspl alleles in Red Danish cattle expressing high and
low milk fat production. Andersson-Eklund and Rendel (1993) reported
evidence for linkage between the amylase-1 locus and a QTL influencing milk fat
content in offspring from heterozgous sires of the Swedish Red and White dairy
breed. Several studies have also shown significant associations between
polymorphisms in milk protein genes and milk production and composition traits
(see Bovenhuis at aI., 1992).
Genetic Markers and QTL: Interval Mapping
Another approach to identifying QTL has been made possible by the
development of genetic linkage maps. This approach, known as interval
mapping, utilizes linkage maps to select genetic markers evenly distributed
throughout a genome. Intervals between pairs of flanking markers are examined
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for evidence of the presence of a QTL. Lander and Botstein (1989) described
methods using maximum likelihood and led scores to determine intervals where
QTL are most likely to exist. More sophisticated statistical analyses are being
developed which will allow for more precise interval mapping as well as the fine
resolution of multiple QTL (Haley et aI., 1994; Zeng, 1994; Jansen and Starn,
1994; Zeng, 1993; Jansen, 1993).
Paterson at al. (1988) first reported the use of interval mapping for the
identification of 15 QTL in the tomato. Approximately 95°A» of the total tomato
genome was estimated to be detectably linked to a total of 68 markers, spaced
at approximately 20 eM intervals, that were used in the study.
Jacob et al. (1991) developed 112 simple sequence repeat markers in
rats which were estimated to cover 90% of the rat genome at a spacing of 30 eM.
These markers were used to screen F2 crosses between hypertensive and
normal rats. Using linkage analyses and LOD scores (Lander and Botstein,
1989), two markers showed significant linkage to blood pressure phenotypes.
These markers were then mapped to mouse chromosomes 10 and 18. Although
a genetic map was not used to select markers to be analyzed in this study.
linkage was found by using interval mapping with a set of markers randomly
distributed throughout a large portion of the genome.
In mice, interval mapping has been successful in identifying QTL for
plasma cholesterol and obesity, as well as morphine preference in inbred strains
(Warden at al., 1993; Berrettini at aI., 1994). Both studies used the statistical
analyses described by Lander and Botstein (1989) to localize QTL to specific
chromosomal regions. The study by Warden at al. (1993) involved backcross
progeny of two inbred lines of mice differing in plasma total cholesterol and total
lipid concentrations. Chromosomal region 7 was found to have significant
linkage to plasma total cholesterol and carcass lipid, and a locus on
4S
chromosome 6 showed significant linkage to plasma total cholesterol. Berrettini
at al. (1994) identified loci on chromosomes 1, 6 and 10 which were responsible
for 85% of variation in oral morphine preference. F2 mice from an intercross of
parental strains differing in their oral preference to addictive substances were
used in the study.
Pomp et al. (1994) identified four QTL having significant effects on body
weight, and four QTL having significant effects on body fat in mice. The average
effect of these markers was in the range of 1-2°k of the phenotypic variation,
except for one marker which may be linked to a pleiotropic marker with larger
effects. The population involved in the study was a backcross population
created from two different inbred mice strains that differed in body size.
Selective genotyping (Lander and Botstein, 1989) was used to identify markers
with an increased likelihood of being linked to QTL. Least-squares procedures
were used to quantitate the effect of inidividual markers on body weight and
body fat.
Andersson et al. (1994) reported the presence of a QTL for growth rate,
fatness, and length of the small intestine on chromosome 4 in pigs using an
interval mapping approach. The study involved a cross between the European
wild boar with the domesticated Large White pig and utilized 105 genetic
markers assigned to 15 of the 18 autosomes. The study demonstrated that
genetic maps can be useful in dissecting genetically quantitative traits in outbred
livestock species and was an application of the analytical method based on least
squares for the identification of QTL segregating in crosses between divergent
outbred lines that was described by Haley et at (1994).
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Marker Assisted Selection
When Sax (1923) and Thoday (1961) first presented the idea of using
genetic markers to study genes regulating quantitative traits, the primary
obstacle was the lack of availability of useful genetic markers. The development
of RFLPs, PCR-RFLPs, microsatellite and SSCP markers have allowed
complete genomes to be represented by informative genetic markers. The
obstacle currently facing animal geneticists is to use genetic markers and
linkage maps to identify QTL important to livestock production. Recent
publications of genetic linkage maps in livestock species (Barandse at aI., 1994;
Bishop et aI., 1994; Rohrer at al.. 1994; Crawford at aI., 1994) along with
ongoing development of new genetic markers will facilitate the systematic
dissection of genomes to allow for detailed searches of QTL (Paterson. 1988;
Lander and Botstein. 1989; Andersson et al.. 1994; Haley at aI., 1994).
Lander and Botstein (1989) discuss methods to increase the efficiency of
identifying genetic markers linked to QTL including identifying promising crosses
for QTL mapping. utilizing the full power of complete linkage maps, and
decreasing the number of progeny to be genotyped. Experimental analysis and
chqice of populations in which to study genetic markers are also crucial to the
successful identification of QTL. The statistical method of maximum likelihood
(Lander and Botstein, 1989) has been successful in identifying QTL in inbred
populations (Paterson at al., 1988; Jacob et at., 1991; Warden at al.. 1993;
Barrettini at al.. 1994), but is computationally complex and difficult to extend to
non-inbred populations (Haley et al.. 1994). Analyses using ordinary least
squares to test for QTL in crosses between divergent outbred lines are
presented by Haley at aI., (1994). Soller and Genizi (1978) compare the
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efficiency of experimental designs using half-sib or full-sib families. The
granddaughter design, which utilizes marker genotypes of sons from
heterozygous sires and phenotypic data from daughters (or sons) of the
genotyped sons, was proposed as a way to decrease the number of animals
genotyped (Weller and Soller, 1990).
The next challenge will be to incorporate information gained from genetic
marker analyses into existing selection programs. Selection based on molecular
genetic information as well as individual phenotypes and breeding value
estimations is known as Marker Assisted Selection (MAS). Although many
details regarding the use of MAS in long term selection programs have yet to be
determined, there is evidence that molecular genetic information has the
potential to substantially increase the efficiency of artificial selection (Lande and
Thompson, 1990). The efficiency of MAS will depend on several factors
including the heritability of the trait being selected, the proportion of additive
genetic variance associated with the marker, and the selection scheme being
used (Lande and Thompson, 1990). The benefits of MAS will be gained through
a decrease in generation interval, increase in accuracy of selection, and the
ability to select animals not expressing a trait. However, it will be important to
maintain realistic expectations of these benefits. MAS is a complex system with
difficulties arising from differences due to environment, genetic backgrounds,
and selection goals (Pomp, 1994). Researchers and the livestock industries
must be willing to work together in order to identify specific goals and
applications for MAS.
Marker assisted selection is still in its infancy, but many obstacles have
already been overcome. Marker assisted selection presents an exciting new




Growth is an economically important trait in beef cattle production that is
regulated by many genes. Traditional selection strategies to improve growth
traits have been based on selecting cattle expressing superior phenotypes for
growth traits. This approach assumes that animals with superior phenotypes
also have superior genotypes, or combinations of genes, influencing growth
traits. However, the combination of genes that creates a superior phenotype in
one animal may not be inherited by the animal's offspring due to the sampling
and recombination of genetic material that occurs during meiosis.
Estimates of the genetic merit for a specific trait that an animal will pass
on to its offspring may be calculated by animal evaluation programs developed
through breed organizations. These estimates are known as expected progeny
differences (EPD) and are equal to one-half of the animal's estimated breeding
value relative to other animals evaluated in the same program. EPD estimates
are useful tools in the beef industry because they are calculated from an
animal's own phenotypic data as well as data collected from ancestors, relatives
and progeny of the animal. EPDs are valuable to selection programs because
they allow selection decisions to be based on more information than simply the
phenotype of an individual.
Techniques from molecular biology have now become available which
may allow even more information to be considered when making selection
decisions. These techniques allow for the evaluation of specific genes of an
animal rather than the evaluation of complete phenotypes. By comparing
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differences, or polymorphisms, in genes among different animals, it may be
possible to identify regions of an animal's genome that are involved in the
regulation of quantitative traits such as growth. Polymorphisms used to identify
these regions, or quantitative trait loci (QTL), would be known as DNA or genetic
markers. Marker assisted selection (MAS) would then incorporate information
gained from examining an animal's DNA using genetic markers with EPD
estimates to assist in making accurate selection decisions.
One obstacle that must be overcome before MAS can be a practical
selection strategy is the identification of DNA markers located in close proximity
to QTL. Many DNA markers have been identified in the bovine genome, but
associations of markers with quantitative traits have not been clearly
established. Another important consideration will be to understand the effects of
a marker in the genetic background in which it will be used. The main objectives
of this study are to characterize specific DNA polymorphisms in three
populations of Hereford cattle, and to identify associations between DNA
markers and growth or maternal traits in a large population of Hereford cattle.
The polymorphisms that were investigated in this study were chosen
based on the candidate gene approach. In order to select candidate genes,
biological factors known to be involved in the regulation of growth were
identified. Polymorphisms in genes encoding these biological regulators were
investigated in hope that the polymorphisms could be used as markers of closely
linked genes involved in the regulation of growth, or that the polymorphisms
themselves result in a biological effect that impacts growth.
Growth Hormone (GH) and insulin-like growth factor I (IGF-I) are
hormones that are important stimulators of growth, and are required for normal
growth to continue in animals. The pituitary transcription factor PIT1 is required
for the expression of the GH gene, and growth hormone receptors (GHR) are
so
necessary in order for GH to carry out its biological action at target tissues.
Genes encoding GH. IGF-I. PIT1 and GHR were chosen as candidate genes for
the study of growth traits. The gene for the hormone prolactin (PRL) was
identified as a candidate gene for the study of milk production because of the
stimulatory action of PRL on lactation. Finally, polymorphisms in genes for the
milk proteins kappa-casein (K-Cas) and beta-lactoglobulin (B-Lac) were
investigated for their effects on milk production and as potential markers of QTL
for growth.
The three populations of Hereford cattle used in the present study differed
in terms of selection pressures, and in the amount of average inbreeding that
has accumulated in the populations. Inbred populations were represented by
the USDA Line 1 Herefords and Lents Anxiety 4th Herefords which have
average inbreeding coefficients of --.30 and .....50, respectively. The USDA line
1 Herefords have been selected for increased growth, but the Lents Axiety 4th
Herefords have not. These populations were compared to a population of 27
Hereford sires chosen from the US Hereford Sire Summary for either high or low
yearling weight EPD. Allele frequencies in these populations were characterized
by evaluating differences in allele frequencies among the populations,
estimating the average amount of genetic variation present in each population,
and determining if alleles were segregating as expected under an assumption of
Hardy-Weinberg equilibrium.
The USDA Line 1 Hereford population was used to test for associations
between DNA polymorphisms and growth or maternal traits. Genotypes were
determined for 420 cattle born in 1991, 1992 and 1993. Phenotypic data and
EPD from these cattle were used to determine if the substitution of one allele for
another allele at a particular locus had a significant effect on growth traits or
maternal ability in the population. A significant effect due to allele substitution
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could indicate the presence of a QTL in close proximity to the polymorphism, or
it could indicate a significant biological effect caused by differences in gene






The Line 1 population of Hereford cattle was established at the Fort
Keogh Livestock and Range Research Laboratory (Miles City, MT) in 1931 as
part of a project to develop a line of cattle superior in genetic merit for growth
(MacNeil et aI., 1992). Two sons of Advance Domino 13th, Advance Domino
20th and Advance Domino 54th, were the primary foundation sires of Line 1, and
the population was closed to outside introduction of germplasm in 1935. Line 1
cattle are recognized for genetic superiority of growth traits and have been used
extensively throughout the Hereford breed. The average expected progeny
differences (EPD) of birth weight, weaning weight, and yearling weight in this
herd for calves born between 1991 and 1993 are -.84,23.0 and 40.3 Ibs.,
resp.ectively. These values compare to average EPDs for Hereford calves born
after January 1, 1991 of +2.3, +26.0 and +42.0 Ibs. for birth weight, weaning
weight and yearling weight, respectively (Bennyshek at aI., 1993).
Husbandry and management practices of Line 1 are described in MacNeil
et at (1992). Briefly, cows are placed in calving pastures in mid-March. Calving
occurs from early April through mid-May. Cow-calf pairs are moved to native
range spring pasture a few days after birth, and then moved to smaller mating
pastures about June 1. After breeding season, cow-calf pairs are moved to
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rangeland summer pastures. Since the mid-1970's calves have been weaned in
mid-October at an average age of 180 days. Cows are moved to autumn range
after weaning. Heifer and bull calves are brought into the feedlot for a two week
adjustment period before being fed growing rations to about one year of age.
Almost 13 generations of selection for increased postweaning gain have
been applied since the Line 1 population was closed. Progeny testing of
potential herd sires was initiated in 1942 and continued until 1960. Bulls that
were used in the Line 1 population during that time were selected from the
results of the progeny test. Since 1960, selection has been based on individual
performance. Adjusted yearling weight has been the primary selection criterion
for male replacements, and 18-month weight has been emphasized in selection
of female replacements. The Line 1 population has been divided into two
sublines since 1976. One subline has been selected for increased yearling
weight while the other subline has been selected by independent culling levels
for increased yearling weight and decreased birth weight.
Trends in predicted breeding values for the Line 1 population were
reported by MacNeil et al. (1992). Postweaning gain predicted breeding values
have increased .29 kg/day, or 2.6 SD, in 13 generations of selection. A 3.2-kg
genetic increase in birth weight has resulted from positive trends in direct and
maternal breeding values for birth weight. Breeding values for 200-day weight
have increased 14.5-kg between 1935 and 1989. However. accumulated effects
of inbreeding have reduced expression of genetic potential for growth and
maternal ability to the extent that the results of selection on 200-day weight have
been slightly more than offset phenotypically.
Inbreeding in the Line 1 population increased rapidly in the late 1930's
and early 1940's due to the mating of daughters of Advance Domino 20th to
Advance Domino 54th and the mating of daughters of Advance Domino 54th to
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Advance Domino 20th. Inbreeding has increased at a lesser rate since that time
because of some avoidance of matings between close relatives. Since 1960.
inbreeding has accumulated at a nearly constant annual rate of .22%/year to
reach the current average inbreeding coefficient of .30. Trends in inbreeding
coefficients in the Line 1 population from 1935 to 1989 are presented in MacNeil
et al. (1992).
A total of 430 animals born in the Line 1 herd in 1991, 1992 and 1993
were involved in the present study. Blood samples were taken at weaning by
jugular bleeding for use in DNA extraction and analysis. All calves were
weighed within 24 hours after birth. Those surviving were weighed at weaning.
at 28-day intervals after weaning, and at approximately 1 year of age. Twelve
sires of 1991 and 1992 calves were used to represent the population for initial
genotyping.
Lents Anxiety 4th Herefords
The Lents Anxiety 4th Herefords located in Indiahoma, Oklahoma, are
owned by Joe and Jim Lents. This is a closed population of cattle with
linebreeding tracing back to the bull Anxiety 4th, one of the founding bulls of the
Hereford breed from the late 1800's. This herd is unique to most Hereford cattle
because it has not been influenced by the Line 1 Herefords and because
selection emphasis has not been placed on increased size.
Cattle from the Lents Anxiety 4th herd involved in this study include 8
herd sires used prior to and during 1992 and 58 calves born in 1992 and 1993.
Blood samples were obtained by jugular bleeding for DNA extraction and
analysis. All calves were weighed at birth and the 1992-born calves were
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weighed at weaning. EPDs were not available for any animals from this herd.
The average birth weight and weaning weight of calves included in this study
were 73 Ib and 404 Ib, respectively. Inbreeding coefficients calculated for the 8
herd sires involved in this study were all greater than .50.
High Yearling Weight EPD Hereford Sires
Thirteen sires with high yearling weight EPDs that also had yearling
weight EPD accuracies greater than .70 were selected from the 1992 U.S.
Hereford Sire Summary (Table 9). This population was included in the study to
represent Hereford cattle from different herds that have a high genetic potential
for growth traits, as indicated by yearling weight EPD. Yearling weight EPDs of
these sires ranged from +80 to +119 with an average of +96.5. This compares
to the breed average of +48.0 lb. for yearling weight EPD in 1992. Semen
samples were obtained from these sires for DNA extraction and analysis.
Low Yearling Weight EPD Hereford Sires
Fourteen sires with low yearling weight EPDs that had yearling weight
EPD accuracies greater than .60 were also selected from the 1992 U.S.
Hereford Sire Summary (Table 9). This population was studied as a comparison
to the High yearling weight EPD sires. Yearling weight EPDs of this group
ranged from -11 to +38 with an average of +17.2. Semen samples were
obtained from these sires for DNA extraction and analysis.
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Table 9: Sires selected from 1992 Hereford sire summary and their EPD and
accuracies for birth weight, weaning weight and yearling weight.
Sire Birth Weight Weaning Weight Yearling Weight
Name EPD Ace EPD Ace EPD Ace
Tex Prime Time 7056 9.9 0.92 67 0.92 119 0.89
JBF Encore GEXPL 4.9 0.80 73 0.81 110 0.76
Power House 5.8 0.88 57 0.88 108 0.83
Knight Ryder 7.4 0.84 68 0.85 107 0.78
HH Magnum 9696 9.2 0.80 65 0.79 106 0.71
JR P183 Rival T025 7.4 0.80 59 0.82 97 0.75
SR Verdict 455 11.0 0.92 63 0.93 96 0.88
IHRY GK Race 4 ET 6.1 0.88 51 0.87 94 0.83
BB Domino 1087 5.7 0.87 50 0.91 86 0.90
MFR Stockman 764 3.0 0.84 44 0.82 84 0.77
WS DHR Duke 8430 6.2 0.93 51 0.94 84 0.91
Klondike Banner 469L 8.4 0.85 59 0.85 84 0.83
GK Explosion 412T 4.0 0.90 42 0.89 80 0.87
4M Hummer 1.2 0.78 21 0.82 38 0.77
OXH Mark 5155 2.1 0.79 17 0.78 36 0.79
CL1 Domino 0005 -1.5 0.91 14 0.91 25 0.89
Selkirk Lad H3 -0.3 0.77 16 0.85 24 0.83
HN Mark Domino 919 0.1 0.82 13 0.85 24 0.79
JCS Mont Donald 191 1.0 0.54 24 0.76 23 0.66
WCF L1 Domino 6164 -1.4 0.53 16 0.68 21 0.63
Selkirk Extra 367 1.7 0.77 18 0.75 20 0.71
L1 Advance 9129 -4.0 0.83 7 0.80 13 0.68
CL1 Domino 113 0.7 0.74 15 0.81 13 0.76
C1 Domino 334 -1.2 0.83 3 0.88 -1 0.87
CL100m 1177 0.5 0.75 9 0.85 -1 0.86
5 Britisher Lad 569 0.9 0.74 6 0.83 -2 0.81
IT Donald 5406 0.1 0.80 -8 0.89 -11 0.87
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DNA Extraction
Genomic DNA was extracted from blood samples taken from animals in
the Line 1 and Lents Anxiety 4th populations. Genomic DNA for the Line 1
population was extracted at the Fort Keogh Livestock and Range Research
Laboratory in Miles City, MT, and then sent to Stillwater, OK for further
processing. All other DNA was extracted in Stillwater, OK Genomic DNA was
extracted from blood samples using the Salt Extraction Protocol (Appendix 1).
Genomic DNA was extracted from semen samples from bulls in the High
and Low Yearling Weight EPD populations. Genomic DNA was extracted from
semen samples using the Organic Solvent Extraction Protocol (Appendix 2).
The concentrations of all stock genomic DNA samples were determined
using a Lambda 3B UVNIS spectrophotometer (Perkin Elmer, Norwalk, CT).
The absorbance of 10 JlI of stock DNA solution diluted in 990 J.11 water was
determined at wavelengths of 260 nm and 280 nm. The concentration of the
stock solution was calculated using the formula (Boyer, 1993):
[DNA] in )lg/ml =(A260)(100)(50J.1g/ml)
where A260 is the absorbance measured at a wavelength of 260 nm, 100 is the
dilution factor used in determining the absorbance, and 50Jlg/ml is the extinction
coefficient for double stranded DNA. Appropriate volumes of stock solutions
were diluted with TE (10 mM Tris-HCI, 1 mM EDTA, pH 8.0) to make 200 J.11 of
DNA working solutions of a final concentration of 50 ng/).11. DNA stock solutions
were stored at -BOoC and DNA working solutions were stored at 4°C. Sample
calculations for determining stock DNA concentration and making 50 ng/JlI DNA
working solutions are shown in Appendix 3.
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The ratio of absorbance at 260 nm to absorbance at 280 nm was used as
an indicator of DNA quality. Ratios between 1.6 and 1.9 were desirable. Lower
ratios indicated protein impurities while higher ratios indicated either RNA or
solvent impurities. All samples were tested in a polymerase chain reaction,
regardless of absorbance ratios. Samples with undesirable ratios that failed to
produce a PCR amplification product were re-extracted using the Organic
Solvent Protocol (Appendix 2) normally used for semen samples for additional
purification. The DNA concentrations of the new samples were determined as
previously described and new working solutions were made.
Genotyping
Polymerase Chain Reaction
All genotyping for this study was based on polymerase chain reaction
(PCR) amplification of a portion of a single gene from genomic DNA. A diagram
of a standard PCR including denaturation. primer annealing and primer
extension steps is shown in Appendix 3. Typically. thermal cycling began with a
single cycle of 2 minutes at 95°C, 1 minute at the annealing temperature specific
for the primer being used in the reaction (55-600C) and 2 minutes at 72°C. This
was followed by 24-29 cycles of 1 minute at 94°C, 1 minute at the annealing
temperature and 1 minute at 720C. All reactions concluded with a final 9 minute
extension at 720C and were then held at 4°C.
All PCRs were carried out in a DNA Thermal Cycler 480 (Perkin Elmer.
Norwalk, CT) or a PTC-100 Programmable Thermal Controller (MJ Research,
Inc.• Watertown, MA). Taq polymerase enzyme and PCR buffer were obtained
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from Boerhinger-Mannheim (Indianapolis, IN). Nucleotides (dATP, dGTP, dCTP
and dTTP) were obtained from New England Biolabs (Beverly, MA) and
combined in a dNTP working solution of 10 mM each nucleotide.
Oligonucleotides for PCR primers were obtained from the OSU
Biochemistry Core Facility (Stillwater, OK). Lyophilized primers were
resuspended in water. Working solutions of 5 IlM each primer (forward primer
and reverse primer) were made for each primer pair. Processing of lyophilized
oligonucleotides and sample calculations are shown in Appendix 5.
Optimization of PCR conditions was carried out for each primer pair. All
optimization reactions were completed in the DNA Thermal Cycler 480. Three
concentrations of MgCl2 (.75 mM, 1.5 mM and 2.25 mM), 2 concentrations of
dNTPs (100 J.1M and 200 JlM each dNTP) and 3 concentrations of primers (0.1 Jl
M, 0.3 IlM and 0.5 IlM each primer) were used in a 3 x 2 x 3 factorial to
determine the optimal concentrations of the reaction ingredients. All
optimizations were carried out in a total volume of 25 IJ,I using .875 units of Taq
polymerase, PCR buffer resulting in final reaction conditions of 10 mM Tris-HCI
and 50 mM KCI at pH 8.3 and 50 ng of genomic DNA. Annealing temperature
for optimization PCR was first tested at 55°C. This temperature was increased if
a more stringent reaction was required to produce a single PCR amplification
product. Reaction conditions resulting in the strongest single amplification
product were used for future PCRs with the optimized primer.
Polymorphisms
Two types of polymorphisms, PCR-based restriction fragment length
polymorphisms (PCR-RFLP) and microsatellite polymorphisms, were used in this
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study_ PCR-RFLPs were represented by polymorphisms in genes for K-casein
(K-Cas), f3-lactoglobulin (B-Lac), growth hormone (GH) and pituitary transcription
factor 1 (PIT1). This type of DNA polymorphism results from a change in the
nucleotide sequence of one allele that either creates or eliminates a recognition
site for a Type II restriction endonuclease. PCR-RFLPs were detected by
digesting PCR amplification products with the appropriate restriction enzyme.
Genotypes were determined using gel electrophoresis to separate the restriction
enzyme digestion products in 3% agarose made with BioRad and NuSieve
agarose in a 1:1 ratio (BioRad, Hercules, CA; Midwest Scientific, St. Louis, MO)
gels. Digestion products were mixed with loading dye and 10 J.l1 were loaded in
the gel. Typically, two combs with 30 wells each were used to form two rows of
wells in gels, and 60 samples were run per gel. DNA was visualized in the gel
by staining for 30 minutes in 1.3 mM ethidium bromide, destaining 30 minutes in
water, and photographing using a Foto Prep I ultraviolet light source and MP4
Instant Camera System (Fotodyne, Inc., Hartland. WI). Unique banding patterns
were observed for each genotype because of differences in restriction enzyme
recognition sites between alleles.
Microsatellite polymorphisms used in this study included polymorphisms
in insulin-like growth factor I (IGF-I) and prolactin (PRL) genes as well as the
random bovine microsatellite marker BM2113. Microsatellites are regions of
tandem repeats of di- or trinucleotide sequences in the genome (Tautz, 1989).
Polymorphisms result from different numbers of tandemly repeating units among
alleles. Polymorphisms were detected using PCR to amplify across the
microsatellite region. The size of the PCR product depended on the number of
tandemly repeating units in the microsatellite region and was used to
characterize different alleles. Genotypes were determined by the size of the
PCR product from polyacrylamide gel electrophoresis. PCR products were run
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as double stranded products on non-denaturing acrylamide gels (Fischer
Scientific. Pittsburgh. PAl and were visulaized by staining in 1.3 mM ethidium
bromide for 20 minutes. destaining in water for 20 minutes and photographing
using a Foto Prep I ultraviolet light source and MP4 Instant Camera System
(Fotodyne, Inc.• Hartland. WI).
The actual base pair length of the PCR products was determined by end-
labelling PCR amplification of each different allele. 33p (DuPont and NENGI>.
Boston. MA) labelled PCR products were run as single stranded DNA on
sequencing gels along with a sequencing standard of known size (see Appendix
6). The length of the PCR product was found by comparison with the known
sequencing standard. After the actual base pair length of PCR products from
DNA samples representing each allele was determined, those samples were
used as standards to genotype additional samples using non-denaturing gels
and ethidium bromide staining.
K-Cas and B-Lac genotyping
K-Cas and B-Lac genotypes were determined as described by Medrano
and Aguilar-Cordova (1989a) and Medrano and Aguilar-Cordova (198gb).
respectively, from a single PCR. The reaction ingredients included: 200 J.1M
each dNTP, 0.1 JlM each K-Cas primer (see Appendix 7),0.1 JlM each B-Lac
primer (see Appendix 7), standard PCR buffer (1.5 mM MgCI2, 10 mM Tris-HCI
and 50 mM KCI at pH 8.3), .75 units of Taq polymerase and 50 ng genomic DNA
in a total volume of 30 Ill. Thermal cycling was carried out as previously
described with an annealing temperature of 60°C for a total of 30 cycles.
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Digestion of the PCR products with the restriction enzyme Hinfl
determined the K-Cas genotype (Medrano and Aguilar-Cordova, 1990a) from the
350 bp K-Cas PCR product. PCR products (11.125 fll> were digested with .125
J.11 (1.25 units) of Hinfl and 1.25 of buffer 2 (New England Biolabs, Beverly, MA)
in 12.5 JJI reactions. Digestion reactions were carried out at 37°C for a minimum
of 3 hours. Gel electrophoresis was carried out as previously described for 50
minutes at 72 volts. K-Cas genotypes were characterized by the following
banding patterns: 134/132 and 84 bp (AA genotype); 266, 134/132 and 84 bp
(AS genotype); and 266 and 84 bp (BB genotype). Three additional
monomorphic bands of approximately 180, 50 and 32 bp resulted from digestion
of products from the B-Lac PCR primers and did not influence the K-Cas
genotype determination.
Digestion of the PCR products with the restriction enzyme Haelll
determined the B-Lac genotype (Medrano and Aguilar-Cordova. 1990b ) from
the 262 bp B-Lac PCR product. PCR products (11.125 J.11) were digested with
.125 JlI (1.25 units) of Haelll and 1.25 of buffer 2 (New England Biolabs, Beverly,
MA) in 12.5 JlI reactions. Digestion reactions were incubated at 37°C for a
minimum of 3 hours. Gel electrophoresis was carried out as previously
described for 50 minutes at 72 volts. B-Lac genotypes were characterized by
the following banding patterns: 350, 153 and 109 bp (AA genotype); 350, 153.
109 and 74"9 bp (AS genotype); and 350, 109 and 74"9 bp (BB genotype).




GH genotypes were determined as described by Zhang et al. (1992).
PCR was carried out in 15 JlI reactions with 200 JlM each dNTPI .3 J.lM each GH
primer (see Appendix 7). standard PCR buffer, .5 units of Taq polymerase and
50 ng genomic DNA. Thermal cycling was carried out as previously described
with an annealing temperature of 58°C for a total of 30 cycles.
The restriction enzyme Alul was used to digest the 427 bp GH PCR
products. PCR products (11.125 J.l1) were digested with .125 J.l1 of Alul (1.25
units) and 1.25 III of buffer 1 (New England Biolabs, Beverly, MA). Digestion
reactions were incubated at 37°C for a minimum of 3 hours. Gel electrophoresis
was carried out as previously described for 45 minutes at 72 volts. GH
genotypes were characterized by the following banding pattems: 264, 96 and
51 bp (AA genotype); 264. 147.96 and 51 bp (AS genotype); and 264 and 147
bp (BS genotype).
PIT1 genotyping
PIT1 genotypes were determined as described by Moody et al. (1994;
App'endix 8). PCR was carried out in 15 III reactions with 200 JlM each dNTP, .1
J.1M each PIT1 primer (see Appendix 7). standard PCR buffer, .5 units of Taq
polymerase and 50 ng genomic DNA. Thermal cycling was carried out as
previously described with an annealing temperature of 55°C for a total of 30
cycles.
The restriction enzyme Hinfl was used to digest the 1355 bp PIT1 PCR
products. PCR products (11.125 Ill) were digested with .125 JlI of Hinfl (1.25
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units) and 1.25 J.11 of buffer 2 (New England Biolabs, Beverly. MA). Digestion
reactions were incubated at 37°C for a minimum of 3 hours. Gel electrophoresis
was carried out as previously described for 45 minutes at 72 volts. PIT1
genotypes were characterized by the following banding patterns: 660, 425 and
270 bp (AA genotype); 660, 425, 385 and 270 bp (AS genotype); and 660, 385
and 270 bp (BB genotype).
GHR genotyping
GHR genotypes were determined as described by Moody and Pomp
(1994; Appendix 9). peR was carried out in 15 III reactions with 200 J.1M each
dNTP, .3 J.1M each GHR primer (see Appendix 7), standard PCR buffer, .5 units
of Taq polymerase and 50 ng genomic DNA. Thermal cycling was carried out as
previously described with an annealing temperature of 55°C for a total of 30
cycles.
The restriction enzyme Alul was used to digest the 2.3-kb GHR PCR
products. PCR products (11.125 J.11) were digested with .125 J.11 of Alul (1.25
units) and 1.25 III of buffer 1 (New England Biolabs, Beverly, MA). Digestion
reactions were incubated at 370C for a minimum of 3 hours. Gel elect~ophoresis
was carried out as previously described for 75 minutes at 72 volts. GHR
genotypes were characterized by the following banding patterns: 785, 670, 375,
195 and 115 bp (AA genotype); 785, 670, 475, 375, 195 and 115 bp (AB
genotype); and 785,475,375, 195 and 115 bp (BS genotype). Only the A allele
of the GHR polymorphism was observed in animals involved in this study, so
GHR genotype was not included in statistical analyses.
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IGF-I genotyping
IGF-I genotypes were determined using PCR primers (see Appendix 7)
designed to amplify the microsatellite described by Kirkpatrick (1992). PCR was
carried out in 15 J.11 reactions using 200 J.1M each dNTP, 0.1 J.1M each IGF-I
primer, standard PCR buffer, .5 units of Taq polymerase and 50 ng genomic
DNA. Thermal cycling was carried out as previously described with an
annealing temperature of 55°C for a total of 25 cycles. Fewer cycles were
required in order to clearly visualize genotypes from polyacrylamide gels.
PCR products were run on non-ctenaturing polyacrylamide gels. A 12%
24:1 (wt:wt) acrylamide:bisacrylamide gel was used to separate the two IGF-I
alleles. peR products were mixed with 3 J.11 of 6X loading dye and 8 J.11 were
loaded in the gel. Typically, 2 gels with 20 wells each were poured. Fifteen
IGF-I PCR products were loaded in each gel along with standards of known AS
genotype. The gels were run for 30 minutes at 385 volts (192.5 v-hr) and 15
more samples were loaded in each gel. Gels were then run 5 hours at 385 volts
(1925 v-hr) to genotype a total of 60 samples. DNA was visualized as previously
described. A 173 bp product was designated as the A allele and corresponded
to the 130 bp allele described by Kirkpatrick (1992), and a 171 bp PCR product
was designated as the B allele and corresponded to the 128 bp allele described
by Kirkpatrick (1992).
PRL genotvping
PRL genotypes were determined using PCR primers designed to flank a
microsatellite region in the 5' region of the bovine prolatin gene (Wolf et aI.,
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1990). PCR was carried out in 15 J.11 reactions using 200 J.1M each dNTP•.2 JlM
each PRL primer (see Appendix 7), standard PCR buffer•.5 units of Taq
polymerase and 50 ng genomic DNA. Thermal cycling was carried out as
previously described with an annealing temperature of 550C for a total of 25
cycles.
PRL PCR products were run on 12% 24:1 (wt:wt)
acrylamide:bisacrylamide non-denaturing polyacrylamde gels as described for
IGF-I, except PRL PCR products were run 30 minutes longer for a total of 2118
v-hr. A 204 bp PCR product was designated as the A allele and a 200 bp PCR
product was designated as the B allele.
BM2113 genotyping
BM2113 microsatellite marker genotypes were determined as described
by Sunden et al. (1993). PCR was carried out in 15 J.11 reactions using 200 J.1M
each dNTP, .2 J.1M each BM2113 primer (see Appendix 7). standard PCR buffer,
.5 units of Taq polymerase and 50 ng genomic DNA. Thermal cycling was
carried out as previously described with an annealing temperature of 550C for a
total of 25 cycles.
BM2113 PCR products were run on 12% 24:1 (wt:wt)
acrylamide:bisacrylamide non-denaturing polyacrylamde gels as described for
IGF-I. except gels were loaded only once and were run 4 hours at 385 for a total




The genotypic data obtained in this study was analyzed in two parts.
The objectives of Part 1were: to determine allele frequencies and variances at
each polymorphism genotyped; to compare allele frequencies among the 4
unique populations; to determine the amount of genetic variance or
heterozygosity present in the populations; and to describe the effects of
inbreeding on gene frequency in the Lents Anxiety 4th and Line 1 populations.
The objective of Part II was to use EPD, phenotyic and genotypic data from the
Line 1 population to test for the presence of a quantitative trait locus (QTL)
linked to a DNA polymorphism. This was accomplished by using regression,
least squares, and animal model analyses.
Part I: Description of Allele and Genotype Frequencies
Genotype Frequencies. Allele Frequencies and Variances. Genotype and
allele frequencies were determined for each polymorphism in each population
using all available genotypes. Genotype frequencies (Puu) were determined for
each possible genotype as the ratio of the number of animals of uu genotype to
the total number of animals genotyped in a population for a given locus. Allele
frequencies (Pu) were determined for each allele as the ratio of one particular
allele (u) to the total number of alleles in the population at a given locus. The
variances of allele frequencies [Var (Pu)l were calculated using the formula
(Weir. 1990):
Var (Pu) =1/2n(pu + Puu - 2Pu2 )
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where: n =total number of animals in population
Pu =frequency of u allele
puu =frequency of uu genotype
Comparison of Allele Frequencies. Allele frequencies were compared
using Chi-Square goodness of fit analyses. Preliminary analyses compared
allele frequencies between High Yearling Weight EPD and Low Yearling Weight
EPD populations. No significant differences in allele frequencies were observed
between the two groups, so they were pooled as one population (pooled EPD)
representing Hereford sires with a wide range in genetic potential for growth
traits. A X2 test statistic was then determined to test for significant differences in
allele frequencies among the 3 populations (Line 1, Lents and pooled EPD) at
each locus (I). A continuity correction factor was used to account for the fact
that a continuous X2 distribution was used to test a hypothesis with discrete
genotypic counts. The X2 test statistic was determined as follows (Weir, 1990):
X21= LpLuX21pu
where: X,21=X2 test statistic for locus I
X21pu =X2 test statistic for allele u of locus I in population p
X21PU = (\obSlpu - eXPlpu\-Q.5)2/ eXPlpu
where: obs1pu = observed number of u alleles in population p at locus I
eXPlpu =expected number of u alleles in population p at locus I
0.5 =continuity correction
eXPlpu =(nu I n)(np)
where: nu =total number of u alleles in all populations being compared
n =total number of all alleles in all populations being compared
np =total number of all alleles in population p
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X21test statistics comparing the three populations were compared to a
table value of 5.99 for a .05 significance level at two degrees of freedom. If
allele frequencies were significantly different among the three populations, then
comparisons were made between two populations using the Chi -square
analysis to determine which populations differed. When two populations were
compared, a table value of 3.84 for one degree of freedom was used to
determine significance at the .05 level.
Similar analyses were performed to test for significant differences in
genotype frequencies among populations. Calculation of the X2 test statistic was
the same, except the number of animals in each genotypic class was used in
place of numbers of alleles. Test statistics comparing three populations were
compared to a table value of 9.49 for a .05 significance level with four degrees of
freedom, and comparisons of two populations were compared to a table value of
5.99 for two degrees of freedom at a .05 significance level.
Genetic Variation. The amount of genetic variation present in each
population was described by calculating a heterozygosity coefficient (HI). HI was
determined for each polymorphism in each population as the ratio of the number
of heterozygotes to the total number of animals genotyped in the population for
the polymorphism. The HI calculated for all polymorphisms were averaged
within populations to estimate the amount of genetic variation in the 4
populations. The variance of HI was calculated using the following formula
(Weir, 1990):
Var (HI) =(1/n)(HI)(1-H1)
where: n = number of a animals in the population
HI =heterozygosity coefficient.
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Comparison with Expectations from Hardy-Weinberg Equilibrium. The
number of animals in each genotypic class was compared to the number of
animals expected under an assumption of Hardy-Weinberg equilibrium using
Chi-square goodness of fit analyses. These analyses were carried out in the
Line 1 population for K-Cas, B-Lac, GH, IGF-I and PIT1 polymorphisms and in
the Lents Anxiety 4th population for K-Cas and GH polymorphisms. The
BM2113 polymorphism was only genotyped in sires representing the two
populations. The remaining polymorphisms were not genotyped in the total
populations because of high frequencies of one allele in sires representative of
the total populations.
The expected number of animals in each genotypic class was calculated
from allele frequencies in each population and Hardy-Weinberg equilibrium
assumptions using the following formulas (Falconer, 1989):
Expected number of AA =p2n
Expected number of AS =2pqn
Expected number of BB = q2n
where: p = frequency of allele A
q =frequency of allele B
n =number of animals in the population
The X2 test statistic, including a continuity correction factor, used to test
for significant differences between observed and expected genotype frequencies
was calculated as follows (Weir, 1990):
X2 ="X2£...J uu
where X2uu ={JObserved number of UU - EXQected number ofUU~~
Expected UU
for each possible genotypic class, UU.
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x2 test statistics were compared to a table value of 5.99 for a .05 significance
level at 2 degrees of freedom.
The same analyses were done after adjusting the expected number of
animals in each genotypic class for known inbreeding coefficients (f) of .30 and
.50 in the Line 1 and Lents Anxiety 4th populations. respectively. Adjusted
expected numbers of animals in each genotypic class were calculated from the
following formulas (Falconer, 1989):
Adj. expected number of AA =(p2 + pqf)n
Adj. expected number of AS =(2pq - 2pqf)n
Adj. expected number of BS =(q2 + pqf)n
where: f = inbreeding coefficient
p =frequency of allele A
q = frequency of allele B
n =number of animals in the population.
Finally. assumptions of Hardy-Weinberg equilibrium were tested using the
t disequilibrium coefficient (DA). The DA and its variance for each polymorphism
was calculated using the formulas (Weir. 1990):
DA =PAA- p2
1
. Var (DA) =_[p2(1-p)2 + (1-2p)2DA - DA2]n
where: PAA =frequency of genotype AA
p =frequency of allele A
n =number of animals in the population
The standard normal variate. z, where (Weir. 1990):
z =(DA-o)/~Var(DA)
was used to test the hypothesis Ho:DA=0, which is equivalent to testing for
Hardy-Weinberg equilibrium expectations because DA is expected to be 0 in a
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population at Hardy-Weinberg equilibrium. A z test statistic greater than 1.96 or
less than -1.96 indicated a significant (P<.05) deviation from Hardy-Weinberg
equilibrium expectations caused by either an excess or deficiency of
heterozygotes (HA:DA not 0). Specifically, a z test statistic greater than 1.64
indicated a significant (P<.05) decrease in the number of heterozygotes
(HA:DA>O), and a z test statistic less than -1.64 indicated a significant (P<.05)
increase in the number of heterozygotes (HA:DA<O) expected from assumptions
of Hardy-Weinberg equilibrium.
Part II: Analyses for QTL
Regression Analyses. Regression analyses were performed to
determine the average effect of allele substitution as described by Falconer
(1989). Birth weight (BWT), weaning weight (WWT), yearling weight (YWT) and
maternal (MILK) expected progeny differences (EPD) were obtained from the
American Hereford Association National Cattle Evaluation for cattle from the
USDA Line 1 population. Regression analyses were performed in which EPDs
were the dependent variables and genotype was the independent variable (EPD
Regression). Genotypes were coded as 0 (AA), 1 (AS) or 2 (B8) to represent
the number of B alleles present for the K-Cas, B-Lac, GH, IGF-I and PIT1
polymorphisms. Regression analyses were also performed in which phenotypic
data for birth weight, weaning weight and yearling weight were the dependent
variables (Regression model 1). Analyses with phenotypes included a combined
fixed effect of year-sax-age of dam, and calving date was included as a
covariate in birth weight analyses. Regression analyses using phenotypic data
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were also performed including sire as an additional fixed effect (Regression
model 2).
Each point in the regression analyses was weighted by the frequency of
the genotype it represented (Table 10). The genotypic frequencies were
calculated for each dependent variable and then averaged across EPD or
phenotype measurement within each marker. Only the genotypes of animals
that were included in the analyses were used to calculate these genotype
frequencies. Genotypes of animals that did not have an EPD or phenotypic
measurement were not considered.
Table 10. Genotype freguencies used to weight regression analyses.
AA AB BB-------
EPDa Phenot~peb EPD Phenotype EPD Phenotye!...
K-Cas .452 .453 .376 .376 .172 .171
B-Lac .523 .520 .395 .400 .082 .080
GH .1 08 .105 .442 .452 .450 .442
IGF-I .427 .427 .399 .394 .174 .179
PIT1 .018 .020 .186 .188 .796 .793
aFrequencies were calculated from animals with EPD estimates included in the
regression analyses.
bFrequencies were calculated from animals with phenotyic records included in
the regression analyses.
As described by Falconer (1989), the regression coefficient (a) estimates
the average effect of allele substitution, or the the average effect of replacing an
A allele with a B allele (Figure 2). The y intercept of the regression line (a)
estimates the average value of the AA genotype. Dominance deviations are
estimated by the difference between observed and predicted values at the AS
genotype (d), and the coefficient of determination, R2. estimates the percentage
of variability of the dependent variable (EPD or phenotype) that is explained by
genotype. The percentage of total variability in phenotype that was explained
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by genotype. and the percentage of residual variability explained when genotype
was added to the model which already contained fixed effects were also
calculated.
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Legend: 'a' represents the average EPD for animals of AA genotype; d
represents the amount of dominance deviation; and the average effect
represents the effect on EPD of replacing an A allele with a B allele.
Least Squares Analyses. Least squares analyses, weighted for genotype
frequencies (Table 10), were performed on BWT EPD, WWT EPD, YWT EPD
and MILK EPD with genotype (AA, AB or BB) included in the model as a fixed
effect (EPD LSM). Linear comparisons tested for differences between
genotypes with additive effects defined as AA - SS and dominance effects
defined as AS - .5(AA + B8).
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Least squares analyses, weighted for genotype frequencies (Table 10)
were performed on birth weight, 200-day weight and 365-day weight phenotypes
using three different models. LSM model 1 included fixed effects of genotype
and year-sex-age of dam subclasses. Calving date was included as a covariate
in birth weight analyses. LSM model 2 included sire as an additional fixed effect
along with genotype and year-sex-age of dam, while LSM model 3 included a
random effect of sire nested within genotype. The random effect of sire nested
within genotype was used as the denominator of the F-test for genotype in LSM
model 3.
LSM models 1, 2 and 3 were performed with all possible 2-way
interactions among genotype, year, sex and age of dam. All non-significant
interactions were eliminated from the models and final analyses were performed
using fixed effects and all interactions that approached significance (P<.20).
Linear comparisons tested for differences between genotypes with additive
effects defined as AA - BS and dominance effects defined as AS - .5(AA + BB).
Animal Model Analysis. An animal model using multiple trait derivative
free reduced maximum likelihood (MTDFREML; Boldman et aI., 1993) was used
to analyze BWT, 200-day weight and 365-day weight phenotypes. A total of 395
anim.als had complete genotype records. All 395 were included in the BWT
analysis, 390 were included in the 200-day weight analysis and 387 were
included in the 365-day weight analysis. For all three traits, an animal effect
was fitted to the data. For BWT and 200-day weight, a maternal genetic effect
and an effect due to permanent environment (repeated records on dams) was
added to the model.
Six fixed effects were fitted to the data. They included a combined year-
age of dam-sex effect plus the five genotype effects (K-Cas, B-Lac, GH, IGF-I
and PIT1). Individual AA, AB and BB genotypes were coded 1, 2 or 3 for the
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analysis. In addition, a covariate for calving day was fit to birth weight. The
numerator relationship matrix contained 6769 individuals and included all
animals described by MacNeil at al. (1992), plus animals born up to and
including 1993. The total number of equations solved were 13801 for BWT,
13799 for 200-day weight and 6806 for 365-day weight. Linear contrasts were
calculated for each trait and each genotype for additive (AA - BB) and




Part I. Description of Allele and Genotype Frequencies
Allele and Genotype Frequencies
GH. B-Lac and K-Cas allele and genotype frequencies are shown in
Figures 3 and 4, respectively; PIT1. IGF-I and PRL allele and genotype
frequencies are shown in Figures 5 and 6, respectively; and BM2113 allele
frequencies are shown in Figure 7. Both A and B alleles were segregating in the
High EPD and Low EPD sire populations at the GH. B-Lac, K-Cas. PIT1. IGF-I
and PRL polymorphisms. Animals in the High EPD and Low EPD populations
displayed 5 and 4 alleles. respectively. of the BM2113 microsatellite marker. A
and B alleles of the GH, B-Lac, K-Cas. PIT1 and IGF-I polymorphisms were both
present in the Line 1 population. but the PRL polymorphism was fixed for the A
allele. Only 2 alleles (139 and 135 bp) of the BM2113 marker were present in
the Line 1 population. A and B alleles of the GH and K-Cas polymorphisms
were segregating in the Lents population, but the PIT1 and PRL polymorphisms
were fixed for the B and A alleles, respectively. One animal from the Lents
population (n=58) was heterozygous at the B-Lac polymorphism while all others
were homozygous for the B allele. One heterozygous sire was identified in the
Lents population for the IGF-I polymorphism while the remaining seven sires
were homozygous for the A allele. At the BM2113 polymorphism, seven Lents
sires were homozygous for the 139 bp allele and one was heterozygous with 139
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and 141 bp alleles. Therefore, the Lents population appears to be close to
fixation for the B, A and 139 bp alleles of the B-Lac, IGF-I and BM2113
polymorphisms, respectively. The A allele of the GHR polymorphism was fixed
in all populations, which is consistent with the observation of fixation of the A
allele in all bas taurus cattle (see Appendix 9).
Comparison of Allele and Genotype Frequencies
Table 11 shows the Chi-square test statistics that were calculated when
testing for differences in allele frequencies among Line 1, Lents, and the pooled
High EPD and Low EPD populations. (Differences in allele frequencies between
the High EPD and Low EPD populations were non-significant for all genotypes).
Values shown in parentheses indicate that at least one expected value in the
analysis was less than five. Because expected values occur in the denominator
of the Chi-square test statistic, small expected values may greatly inflate the test
statistic. When comparing these values to a table value of 5.99 for a .05
significance level at 3 degrees of freedom, these results indicate that significant
differences (P<.05) in allele frequencies among the three populations exist at the
B-Lac, GH, IGF-I, PRL, PIT1 and BM2113 polymorphisms.
Results from two-way comparisons (Table 11) indicate that all three
populations had different (P<.05) allele frequencies for the B-Lac polymorphism.
GH and BM2113 allele frequencies in the pooled EPD population differed
(P<.05) from frequencies in both the Line 1 and Lents populations, but
frequencies in the Line 1 and Lents populations did not differ from each other.
IGF-I allele frequencies in the Lents population differed (P<.05) from allele
frequencies in both the Line 1 and pooled EPD populations, but allele
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frequencies in the Line 1 and pooled EPD populations did not differ from each
other. Allele frequencies for the PIT1 polymorphism were different (P<.05)
between the pooled EPD and Lents populations, but allele frequencies in the
Line 1 population did not differ from either the pooled EPD or Lents population
frequencies. Allele frequencies for the PRL polymorphism were different (P<.05)
between the pooled EPD and Line 1 populations, but allele frequencies in the
Lents population did not differ from either the pooled EPD or Line 1 population
frequencies.
Table 12 shows the Chi-square test statistics that were calculated when
testing for differences in genotype frequencies among Line 1, Lents and the
pooled EPD populations. These results indicate that differences (P<.05) in
genotype frequencies among the three populations exist at the GH, B-Lac, PIT1
and IGF-I polymorphisms. Results from two-way comparisons indicate that
differences in genotype frequencies at the GH, B-Lac, PIT1 and IGF-I
polymorphisms are the same as the differences in allele frequencies previously
described.
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a,b,Cpopulations with different superscripts have significantly different allele
frequencies
Yactual allele frequencies
zallele frequency variance (x 10-3)
+no differences in allele frequency between High and Low EPD sires were
significant
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Low EPD Pooled EPD a
a,b,Cpopulations with different superscripts have significantly different genotype
frequencies
Zactual genotype frequencies
+no differences in genotype frequencies between High and Low EPD sires were
significant
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High EPO Low EPO Pooled EPOb
a,bpopulations with different superscripts have significantly different allele
frequencies
Yactual allele frequencies
zallele frequency variance (x 10-3)
+no differences in allele frequency between High and Low EPD sires were
significant
83















High EPD+ Low EPD Pooled EPD b
Lents b
.41 .48
















Lents a High EPD Low EPD Pooled EPD aLine 1 a
-
- .69 .71 .70
-
- .31 29 30








a,bpopulations with different superscripts have significantly different genotype
frequencies
Zactual genotype frequencies
+no differences in genotype frequencies between High and Low EPD sires were
significant
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a,bpopulations with different superscripts have significantly different allele frequencies
Yactual allele frequencies
zallele frequency variances (x 10-3)
Table 11. Chi-square test statisticsa calculated for comparisons of allele
frequencies among populations.
Polymorphism EPD/Line1/Lents Line1/Lents Line1/EPD Lents/EPD
K-Cas 0.60
B-Lac 238.63* 221.09* 38.87*
GH 34.55* 3.37 33.07*
IGF 7.48* 7.00* 0.56
PIT1 10.07* (3.08) 6.76*
PRL (8.29*) (0.26) (4.90*)







*Indicates a significant difference (P<.05) in allele frequency
aValues shown in parentheses indicate at least one expected value in the
analysis was less than five.
Table 12. Chi-square test statisticsa calculated for comparisons of genotype
frequencies among populations.
















PRL (10.77*) (5.71) (5.17)
*Indicates a significant difference (P<.05) in allele frequency
aValues shown in parentheses indicate that at least one expected value in the
analysis was less than five.
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Genetic Variation
Heterozygosity coefficients (HI) and variances for each polymorphism in
each population are shown in Figure 8, along with the average HI. The average
HI indicates that the pooled EPD population had the highest, and the Lents
population the lowest average genetic variation. This trend was observed
specifically at the IGF-I, PIT1 and BM2113 polymorphisms. Genetic variation at
the PRL polymorphism existed in the pooled EPD population (H1=O.29) but not in
the Line 1 or Lents populations (H1=O). Almost no variation at the B-Lac
polymorphism was present in the Lents population (H1=.02), but genetic
variability was similar in the Line 1 (H1=.40) and pooled EPD (HI=.41)
populations for the B-Lac polymorphism. For the K-Cas and GH polymorphisms.
the least amount of genetic variation was observed in the Line 1 population (K-
Cas HI =.38; GH HI = .46). The pooled EPD population had the greatest genetic
variability at the K-Cas polymorphism (H,=.52), while the Lents population had
the greatest genetic variability at the GH polymorphism (H1=.60).
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Comparisons with Expectations of Hardy-Weinberg Equilibrium
Results from the Chi-square goodness of fit analyses to test assumptions
of Hardy-Weinberg equilibrium in the Line 1 and Lents populations are shown in
Figures 9 and 10, respectively. Numbers of animals in each genotypic class in
the Line 1 population did not differ significantly (P>.05) from expectations of
Hardy-Weinberg equilibrium at the PIT1, GH or B-Lac polymorphism, but
differed (P<.05) after adjusting expected numbers for known inbreeding (f=.30).
The difference from adjusted expected numbers resulted from a lack of increase
in the number of homozygotes that is expected in inbred populations (Falconer,
1989). The observed numbers of animals in each genotypic class at the IGF-I
polymorphism were intermediate between the expected numbers and the
adjusted expected numbers. An increase in the number of homozygotes
expected based on an assumption of Hardy-Weinberg equilibrium was observed,
resulting in a difference (P<.05) between observed and expected numbers.
However, this increase was not as large as the increase predicted by adjusting
expected values for known inbreeding, resulting in a significant difference
(P<.05) between observed and adjusted expected numbers at the IGF-I
polymorphism. Observed numbers of animals in each genotypic class of the K-
Cas polymorphism did display the increase in homozygosity that was predicted
when adjustments for inbreeding were made (P>.05), but differed (P<.05) from
the expected numbers without adjustments for inbreeding.
In the Lents population, the observed numbers of animals in each
genotypic class at the K-Cas and GH polymorphisms did not differ (P>.05) from
expected numbers, but did differ (P<.05) from expected numbers that were
adjusted for a known inbreeding coefficient of .50.
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Table 13 shows results obtained when testing assumptions of Hardy-
Weinberg equilibrium using disequilibrium coefficients (0A; Weir. 1990). When
considering departures from Hardy-Weinberg equilibrium due to either an
excess or deficiency of homozygotes (Ho: DA=O vs. HA: 0A not 0). the line 1
population differs (P<.05) from Hardy-Weinberg equilibrium expectations at the
IGF-I and K-Cas polymorphisms but not at the B-Lac. GH or PIT1
polymorphisms (P>.05). The same analysis in the Lents population indicates no
difference (P>.05) from Hardy-Weinberg equilibrium expectations at either the K-
Cas or GH polymorphism.
When considering only an excess (Ho: 0A=O vs. HA: OA<O; 50/0
significance level at z < -1.64) or only a deficiency (Ho: DA=O vs. HA: DA>O; 5%
significance level at z >1.64) of heterozygotes. results indicate a deficiency of
heterozygotes (P<.05) at the K-Cas and IGF-I polymorphisms in the Line 1
population. Results also indicate a significant (P<.05) excess of homozygotes in
the Lents population for the GH polymorphism.
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Figure 9: Results from Chi-square goodness of fit analyses to test assumptions
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aNumber of Line 1 animals in each genotypic class
bExpected number of animals in each genotypic class based on an assumption of Hardy-
Weinberg equilibrium
CExpected number of animals in each genotypic class based on an assumption of Hardy-
Weinberg equilibrium after adjusting for known inbreeding level
dChi-square test statistic comparing expeded numbers to observed numbers
eChi-square test statistic comparing adjusted expeded numbers to observed numbers
* indicates a significant difference (P<.05) between observed numbers expeded or adjusted
expected numbers in each each genotypic class
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Figure 10: Results from Chi-square goodness of fit analyses to test assumptions




























Observed Expected Adj. Expected
8Number of Line 1 animals in each genotypic class
bExpected number of animals in each genotypic class based on an assumption of Hardy-
Weinberg equilibrium
cExpected number of animals in each genotypic class based on an assumption of Hardy-
Weinberg equilibrium after adjusting for known inbreeding level
dChi-square test statistic comparing expeded numbers to observed numbers
eChi-square test statistic comparing adjusted expeded numbers to observed numbers
* indicates a significant difference (P<.05) between observed numbers expeded or adjusted
expected numbers in each each genotypic class
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Table 13. Results from tests of assumptions of Hardy-Weinberg equilibrium in































Part II: QTL Analysis
Regression Analyses
The number of observations, means and standard deviations for EPDs
and phenotypic data used in statistical analyses for markers of QTL in the Line 1
population are presented in Table 14. The number of observations varies
because of missing EPDs or phenotypic data.
Table 14: Summary of Line 1 EPD and phenotypic data included in QTL
analyses.
Trait n MeanS Standard ErrorS
BWTEPD 401 -0.8441 0.1196
WWTEPD 402 23.0075 0.3115
YWTEPD 402 40.3159 0.5219
MILK EPD 388 -2.6675 0.3058
Birth Weight 418 80.8589 0.6000
Weaning Weight 413 457.4201 3.6597
Yearling Weight 410 847.0567 6.5561
apounds
Results from the regression analyses of BWT, WWT, YWT and MILK
EPD on genotype (EPD regression) are shown in Table 15. Substitution of an A
allele with a B allele had significant effects on BWT EPD for the K-Cas, B-Lac
and IGF-I polymorphisms (P<.01), and for the PIT1 polymorphism (P<.05). The
effect of substituting a B allele for an A allele on WWT EPD was significant for
K-Cas (P<.01) and IGF-I (P<.05) polymorphisms, while the effect of allele
substituion on YWT EPD was significant only for the K-Cas polymorphism
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(P<.01). The effect of allele substitution on MILK EPD was significant (P<.01 )
for the K-Cas, GH and IGF-I polymorphisms.
The percentage of variability in EPD explained by genotype is also
presented in Table 15 and ranges from 0.01 % to 11.33%. The largest
percentage of variability in 8WT EPD was explained by K-Cas (9.04%) and IGF-
1(6.44%) polymorphisms. B-Lac and PIT1 polymorphisms also had significant
effects on 8WT EPD, but explained a smaller percentage of 8WT EPD
variability (2.06% and 1.07%, respectively). K-Cas and IGF-I genotype
accounted for 2.05% and 1.07% of the variability in WWT EPD while K-Cas
genotype explained 2.13% of YWT EPD variability. K-Cas genotype explained
11.33% of the variabilty in MILK EPD while the significant effects of GH and IGF-
I accounted for 1.66% and 2.88%, respectively, of MILK EPD variation.
Estimates of dominance deviations were not significant for any traits. EPD
means observed for each genotype and the predicted means estimated from
regression analyses are shown in Appendix 10.
Results from the regression analyses of birth weight, 200-day weight and
365-day weight on genotype without sire in the model (Regression Model 1) are
shown in Table 16. Substituting a B allele for an A allele had a significant effect
on 8WT for the K-Cas polymorphism (P<.01) and for the B-Lac and IGF-I
polymorphisms (P<.05). The effect of allele substitution on 200-day weight was
significant for the K-Cas polymorphism (P<.05) and approached significance for
the IGF-I polymorphism (P<.1 0). The effect of allele substitution on 365-day
weight was not significant for any of the polymorphisms analyzed.
The percentage of total variability as well as the percentage of residual
variability explained by genotype for each trait are also presented in Table 16.
The largest amount of variabilty explained by genotype was 1.53% of total and
2.23% of residual variability in 8WT explained by K-Cas genotype. B-Lac
9S
genotype explained 1.05% of total and 1.57% of residual variability in BWT while
IGF-I genotype accounted for 0.81 % of total and 1.20% of residual variability in
BWT. K-Cas genotype explained 0.63% of total and 1.23% of residual variability
in 200-d WT and IGF-I genotype accounted for 0.40% of total and 1.20% of
residual variability in 200-d WT. Estimates of dominance deviations were not
significant for any traits analyzed. Estimates of a. or the average weight of
animals with the AA genotype, are not presented because the predicted value
from the regression analysis is biased.
Results from the regression analyses of birth weight, 200-day weight and
365-day weight on genotype with sire included in the model as a fixed effect
(Regression model 2) are shown in Table 17. The effect of allele substitution at
the B-Lac polymorphism on birth weight (P<.01 ) was the only significant effect.
S-Lac genotype accounted for 0.97% of total and 1.81 % of residual variability of
8WT in this analysis.
Results of the three different regression models (EPD Regression,
Regression Model 1 and Regression Model 2) are summarized in Table 18.
Significant effects from EPD Regression and Regression Model 1 analyses were
similar, with the exception of significant effects of K-Cas and PIT1 genotypes on
BWT EPD that were not observed for BWT from Regression Model 1. Inclusion
of sire in the model (Regression Model 2) removed all significant effects of allele
substitution on phenotype. with the exception of the the effect of B-Lac genotype
on birth weight.
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Table 15: Results from regression analyses (EPD regression) of birth weight
(BWT EPD). weaning weight (WWT EPD). yearling weight (YWT EPD)
and maternal (MILK EPD) EPD.
aa a b de %vard
K-Cas
BWTEPD -0.051 ± 0.148 -1.113 ± 0.178** -0.076 ± 0.210 9.04
WWTEPD 24.000 ± 0.403 -1.388 ± 0.483** -0.303 ± 0.543 2.05
YWTEPD 42.070 ± 0.666 -2.342 ± 0.798** -0.426 ± 0.946 2.13
MILKEPD -0.422 ± 0.376 -3.158 ± 0.453** -0.072 ± 0.512 11.33
B-Lac
BWTEPD -0.509 ± 0.150 -0.662 ± 0.232** -0.029 ± 0.175 2.06
WWTEPD 22.690 ± 0.391 0.461 ± 0.604 -0.073 ± 0.522 0.15
YWTEPD 39.769 ± 0.650 0.970 ± 1.001 -0.036 ± 0.848 0.24
MILK EPD -2.126 ± 0.385 -0.788 ± 0.597 0.197 ± 0.511 0.46
GH
BWTEPD -0.958 ± 0.339 0.130 ± 0.217 0.054 ± 0.175 0.09
WWTEPD 22.882 ± 0.885 0.133 ± 0.814 0.053 ± 0.485 0.01
YWTEPD 38.681 ± 1.487 1.322 ± 0.949 0.174 ± 0.846 0.49
MILKEPD -4.460 ± 0.861 1.392 ± 0.549** 0.086 ± 0.440 1.66
IGF-I
BWTEPD -1.516 ± 0.162 0.971 ± 0.187** 0.123 ± 0.188 6.44
WWTEPD 22.256 ± 0.427 1.016 ± 0.493* -0.119 ± 0.502 1.07
YWTEPD 39.739 ± 0.724 0.740 ± 0.836 -0.479 ± 0.841 0.20
MILK EPD -3.853 ± 0.429 1.642 ± 0.491 ** 0.244 ± 0.468 2.88
PIT1
BWTEPD 1.068 ±0.292 -1.069 ± 0.516* 0.002 ± 0.262 1.07
WWTEPD 24.936 ± 2.702 -1.098 ± 1.379 -0.011 ± 0.681 0.16
YWTEPD 44.788 ± 4.538 -2.510 ± 2.315 0.001 ± 1.167 0.30
MILKEPD 0.711 ± 2.790 -1.889 ± 1.422 0.048 ± 0.597 0.46
**P<.01, *P<.05. +P<.10
8average EPD of the AA genotype
baverage effect of allele substitution (pounds)
cdominance deviation (pounds)
dpercentage of variability of EPD explained by genotype.
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Table 16: Results from regression analyses (Regression model 1) of birth
weight. 200-day weight and 365-day weight on genotype.
a,a db %Totc % Resd
K-Cas
BWT -2.427 ± 0.815** -0.296 ± 0.824 1.53 2.23
200-dWT -93468 ±4.328* -1.360 ± 3.963 0.63 1.23
365-d WT -9.776 ±6.649 -0.497 ± 6.370 0.21 0.56
B-Lac
eWT -2.467 ± 0.998* -0.133 ± 0.766 1.05 1.57
200-d WT -2.143 ± 5.408 -0.532 ± 4.233 0.04 0.04
365-d WT -5.347 ± 8.237 -1.237 ± 6.813 0.04 0.11
GH
BWT 0.037 ± 0.965 0.054 ± 0.708 0.00 0.00
200-d WT 0.522 ± 5.102 0.477 ± 3.882 0.00 0.00
365-d WT -0.742 ± 7.810 0.761 ± 5.756 0.00 0.00
IGF-I
BWT 1.772 ± 0.819* 0.359 ± 0.817 0.81 1.20
200-d WT 7.318 ± 4.236+ -1.891 ± 4.348 0.40 0.78
365-d WT 4.665 ± 6.579 -1.425 ± 6.922 0.05 0.14
PIT1
8WT -1.437 ±2.214 -0.100 ± 1.149 0.07 0.11
200-d WT -9.655 ± 11.663 0.109 ± 6.370 0.09 0.18
365-d WT -20.038 ± 18.132 0.715 ± 9.394 0.12 0.32
**P<.01. *P<.05, +P<.10
aaverage effect of allele substitution (pounds)
bdominance deviation (pounds)
cpercentage of total variance explained by genotype
dpercentage of residual variance explained by genotype
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Table 17. Results from regression analyses (Regression model 2) of birth
weight, 200-day weight and 365-day weight on genotype with sire
included in the model as a fixed effect .
a,8 db %Totc o~ Resd
K-Cas
BWT -0.589 ± 0.989 -0.429 ± 0.750 0.06 0.10
200-dWT -3.802 ± 5.451 -2.021 ± 3.733 0.06 0.13
365-dWT -2.061 ± 8.315 -2.673 ± 5.749 0.01 0.02
B-Lac
BWT -2.777 ± 1.078** -0.116 ± 0.739 0.97 1.81
200-d WT -4.264 ± 6.122 -0.434 ± 3.979 0.06 0.14
365-d WT -9.869 ± 9.308 -1.456 ± 6.279 0.10 0.32
GH
BWT -0.201 ± 0.984 0.043 ± 0.638 0.01 0.01
200-d WT 0.813 ± 5.471 0.336 ± 3.573 0.00 0.01
365-d WT -4.065 ± 8.207 0.868 ± 5.163 0.02 0.07
IGF
BWT -1.506 ± 1.005 -0.028 ± 0.717 0.33 0.61
200-d WT -1.658 ± 5.479 -2.543 ± 4.044 0.01 0.03
365-dWT -4.493 ± 8.271 -1.650 ±6.353 0.03 0.08
PIT1
BWT -0.500 ±2.229 -0.148 ± 1.048 0.01 0.01
200-d WT -6.016 ± 12.296 0.055 ± 6.509 0.03 0.07
365-d WT -14.400 ± 18.745 0.609 ± 9.835 0.05 0.16
**P<.01. *P<.05, +P<.10
aaverage effect of allele substitution (pounds)
bdominance deviation (pounds)
cpercentage of total variance explained by genotype
dpercentage of residual variance explained by genotype
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Table 18: Comparison of regression analyses to determine the average effect of
allele substitution for each polymorphism.
Model Birth Weight Weaning Weight Yearling Weight Milk
K-Cas
EPD ** ** ** ..
Model 1 ** * ns
Model 2 ns ns ns
B-Lac
EPD ** ns ns ns
Model 1 * ns ns
Model 2 ** ns ns
GH
EPD ns ns ns ..
Model 1 ns ns ns
Model 2 ns ns ns
IGF-I
EPD ** * ns **
Model 1 * + ns
Model 2 ns ns ns
PIT1
EPD * ns ns ns
Model 1 ns ns ns
Model 2 ns ns ns
** P<.01, * P<.05, + P<.1 0, ns P>.10
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Least Squares Analyses
Results from least squares analyses of EPDs (EPD LSM) are shown in
Table 19. Main effects of K-Cas (P<.01), IGF-I (P<.01) and B-Lac (P<.05)
genotypes on BWT EPD were significant. Results from contrasts indicated
significant (P<.01) additive gene action on BWT EPD due to K-Cas and IGF-I
genotype, but neither additive nor dominant gene action was significant for the
B-Lac polymorphism (P>.10). The main effect of K-Cas genotype on WWT EPD
was significant (P<.01), and the main effect of IGF-I genotype on WWT EPD
approached significance (P<.1 0). In both cases, the effect was caused by
additive gene action. The main effect of K-Cas genotype on YWT EPD was
significant (P<.01), and was due to additive gene action (P<.05). Main effects of
K-Cas (P<.01), IGF-I (P<.01) and GH (P<.05) genotype on MILK EPD were
significant. Additive gene effects of K-Cas (P<.01) and IGF-I (P<.05) genotype
were significant, and additive gene effects of GH genotype (P<.1 0) approached
significance.
The largest percentage of variability in BWT EPD was explained by K-
Cas genotype (9.13°k) followed by IGF-I (6.700k) and B-Lac (2.10%) genotype.
K-Cas genotype accounted for 2.26% of the variability in WWT EPD and 2.29%
of the variability in YWT EPD, while IGF-I explained 1.11 % of WWT EPD
variability. The largest percent of variability in MILK EPD was explained by K-
Cas genotype (11.34%) followed by IGF-I (3.04%) and GH (1.72%) genotype.
Results from least squares analyses of phenotypic data including
significant two-way interactions (LSM Model 1) are shown in Table 20. The main
effect of K-Cas genotype on BWT was significant (P<.01), and the significant
effect was due to additive gene action (P<.05). The main effect of IGF-I
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genotype on SWf approached significance (P<.1 0), but neither contrast testing
for additive nor dominant gene action was significant (P>.1 0). The main effect of
B-Lac genotype on SWf was significant (P<.01) when no interactions were
included in the model, but was non-significant when interactions of B-Lac x age
of dam. B-Lac x year, age of dam x year, age of dam x sex and sex x year were
included in the analysis. The main effect and additive gene effect of K-Cas
genotype on 200-day weight approached significance (P<.1 0), and the additive
gene effect of IGF-I genotype on 20Q-day weight was significant (P<.05).
K-Cas genotype accounted for 1.67°~ of total and 2.34°~ of residual
variability of SWf while IGF-I genotype explained 0.88% of total and 1.27% of
residual variability. K-Cas genotype explained 0.67°k of total and 1.29% of
residual variability in 200-day weight while IGF-I genotype accounted for 0.54%
of total and 1.03% of residual variability in 200-day weight.
No main effects of genotype were significant when either sire or sire
nested within genotype were included in the least-squares model (LSM Model 2
and LSM Model 3). Results from least squares analyses (EPD LSM, LSM Model
1. LSM Model 2 and 3) are summarized in Table 21. Significant effects of K-Cas
genotype on 365-day weight and B-Lac genotype on SWf were observed from
the EPD LSM analysis but not from the LSM Model 1 analysis. Otherwise, least
squares analyses of EPDs and phenotypic data were similar.
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Table 19. Results from least squares analyses (EPD LSM) of birth weight (BWT
EPD), weaning weight (WWT EPD), yearling weight (YWT EPD) and
maternal (MILK EPD) EPD.
MEa Additiveb Dominancec %Vard
K-Cas
BWTEPD ** 2.074 ± 0.431** -0.179 ± 0.285 9.13
WWTEPD ** 2.164 ± 1.170+ -0.715 ± 0.771 2.26
YWTEPD ** 3.827 ± 1.934* -1.002 ± 1.275 2.29
MILK EPD ** 6.159 ± 1.115** -0.175 ± 0.725 11.34
B-Lac
BWTEPD * 0.993 ± 0.979 -0.204 ± 0.529 2.10
WWTEPD ns -1.758 ± 2.556 -0.512 ± 1.381 0.19
YWTEPD ns -2.346 ± 4.242 -0.249 ± 2.292 0.24
MILK EPD ns 3.787 ± 2.518 1.358 ± 1.362 0.72
GH
BWTEPD ns -0.681 ±0.829 0.290 ± 0.404 0.22
WWTEPD ns -0.682 ± 1.902 0.286 ± 1.054 0.03
YWTEPD ns -4.009 ±3.194 0.940 ± 1.769 0.56
MILK EPD * -3.483 ± 1.876+ 0.476 ± 1.036 1.72
IGF-I
BWTEPD ** -1.674 ±0.451** 0.308 0.290 6.70
WWTEPD + -2.295 ± 1.190* -0.302 ± 0.764 1.11
YWTEPD ns -2.539 ± 2.016 -1.216 ± 1.295 0.42
MILK EPD ** -2.754 ± 1.177* 0.618 ± 0.756 3.04
PIT1
BWTEPD ns 2.027 ± 5.387 0.058 ±2.742 1.07
WWTEPD ns 2.831 ± 14.398 -0.329 ±7.328 0.16
YWTEPD ns 4.945 ±24.176 0.038 ± 12.304 0.30
MILK EPD ns 1.354 ± 14.285 1.261 ± 7.281 0.47
**P<.01, *P<.05, +P<.10, ns:P>.10
amain effect of genotype
bcontrasts testing for additive gene action
Ccontrasts testing for dominant gene action
dpercentage of variability in EPD explained by genotype
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Table 20. Results from least squares analyses (LSM Model 1) of birth weight.
200-day weight, and 365-day weight.
MEa Additiveb Dominancec %Totd ok Res8
K-Cas
BWT ** 4.375 ± 1.970* -0.672 ± 1.298 1.67 2.34
200-d wt. + 17.221 ± 10.481+ -2.439 ± 0.937 0.67 1.29
365-d wt. ns 18.177 ± 16.121 -1.905 ± 10.562 0.22 0.58
B-Lac
BWT ns 1.370 ± 5.513 -1.335 ± 2.890 0.55 0.89
200-d wt. ns -1.066 ± 23.096 -4.694 ± 12.406 0.07 0.14
365-d wt. ns -6.228 ± 35.010 -9.623 ± 18.819 0.06 0.16
GH
BWT ns -1.157 ± 3.290 0.374 ± 1.811 0.14 0.20
200-d wt. ns -6.739 ± 17.194 3.184 ± 9.424 0.02 0.04
365-d wt. ns -7.062 ± 26.175 4.076 ± 14.360 0.01 0.02
IGF-I
BWT + -2.657 ± 1.917 0.943 ± 1.248 0.88 1.27
200-d wt. ns -19.958 ± 9.985* -5.866 ± 6.493 0.54 1.03
365-d wt. ns -8.966 ± 15.714 3.644 ± 10.138 0.03 0.09
PIT1
BWT ns 6.637 ± 20.995 -1.933 ± 10.723 0.08 0.12
200-d wt. ns 12.029 ± 110.814 1.382 ± 56.628 0.05 0.10
365-d wt. ns -0.356 ± 170.097 18.423 ± 86.977 0.09 0.24
**P<.01, *P<.05, +P<.10, ns:P>.10
amain effect of genotype
bcontrasts testing for additive gene action
Ccontrasts testing for dominant gene action
dpercentage of total variability explained by genotype
epercentage of residual variability explained by genotype
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Table 21: Comparison of results from least squares analyses of EPDs. Model 1
and Models 2 and 3. Significance levels are presented for the main effect
of genotype.
Birth Weight WeaningWt Yearling Wt MILK EPD
K-Cas
EPD ** ** ** **
Model 1 .. + ns
Model 2.3 ns ns ns
B-Lac
EPD • ns ns ns
Model 1 ns ns ns
Model 2.3 ns ns ns
GH
EPD ns ns ns *
Model 1 ns ns ns
Model 2.3 ns ns ns
IGF-I
EPD .. + ns **
Model 1 + ns ns
Model 2.3 ns ns ns
PIT1
EPD ns ns ns ns
Model 1 ns ns ns
Model 2,3 ns ns ns
**P<.01. *P<.05, +P<.10. ns P>.10
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Animal Model Analysis
Results from the Animal Model analysis are shown in Table 22. Contrasts
testing for additive and dominant gene action indicated no significant effects of
genotype on birth weight, weaning weight or yearling weight. These results are
consistent with results from regression and least squares analyses which
included sire as a fixed effect in the model.
Table 22. Results from animal model analysis of BWT, 200-day weight and 365-
day weight for contrasts (pounds) for additive and dominance effects8 .
8WT 200-day weight 365-day weight
K-Cas
additive 1.2 ± 1.8 11.8 ± 8.8 7.5±15.5
dominance -1.3±1.1 -5.1 ±5.5 -8.4 ± 9.2
B-Lac
additive 2.3 ± 2.1 -9.3 ±9.6 -9.1±17.1
dominance -1.D±1.2 -0.1 ±5.8 -8.3 ± 10.1
GH
additive D.7 ±2.D -1.3 ±9.3 1.4 ± 16.3
dominance 0.3 ± 1.2 2.6 ±5.6 6.4 ±9.7
IGF~I
additive 2.1±1.9 -5.0 ±8.8 -0.7 ± 15.7
dominance 0.2 ± 1.1 -2.7 ±5.3 -5.9 ±8.9
PIT1
additive 3.0 ±4.1 -6.6 ± 21.7 -22.7 ± 33.6
dominance -1.8 +2.2 4.6 ± 11.9 25.5 ± 18.5




Part I: Characterization of DNA Polymorphisms in 4 Populations
of Hereford Cattle
Allele Frequencies
Frequencies of the K-Cas A allele were .64, .60 and .63 in the Line 1,
Lents and pooled EPD populations, respectively. These frequencies compare to
earlier reports of .85 for Holstein (Medrano, 1990) and .10 for Jersey (Medrano
and Aguilar-Cordova, 1990a). Medrano (1990) reported a B-Lac A allele
frequency of .40 in Holstein, which is similar to .31 observed for the pooled EPD
population, but much lower than .72 observed in the Line 1 population, and
higher than .01 observed in the Lents population.
Zhang et al. (1993) reported GH A allele frequencies of .91, .73, .74 and
.65 for Holstein, Simmental, Angus and Herefords, respectively. GH A allele
frequency observed in the pooled EPD population (.72) is similar to the previous
report for Herefords, but GH A allele frequencies observed in Line 1 (.33) and
Lents (.42) populations are considerably lower. Kirkpatrick (1992) reported an A
allele frequency of .26 for IGF-I in a mixed-breed population, which is much
lower than observations of .62, .94 and .65 for the Line 1, Lents and pooled EPD
populations, respectively_ These results indicate significant between-breed and
within-breed variation in allele frequency at many loci.
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Differences in Allele Frequencies in Hereford Populations
Changes in allele frequencies in a population may be caused by several
factors including selection, random genetic drift, migration and mutation.
Inbreeding enables gene frequencies of a population to drift more rapidly by
limiting the sample of gametes available for the next generation. Differences in
allele frequencies between populations may also result from differences in allele
frequncies among the founder animals of the different populations, and from
sampling error in determining actual allele frequencies.
When considering the differences in allele frequencies that were
observed at six of the seven polymorphisms studied in three different Hereford
populations, it is not clear which factor(s} are responsible for the observed
differences. Differences in selection emphasis has likely influenced allele
frequencies of the populations. The Line 1 population has undergone
continuous selection pressure for increased yearling weight. while selection
emphasis in the Lents population has been less specific. Sires in the High EPD
population were chosen to represent Hereford cattle in which selection for
increased growth had been successful, and sires in the Low EPD were chosen
to represent Hereford cattle in which superior growth traits are not observed. If
selection was the primary force influencing the allele frequencies of these
populations, it could be expected that allele frequencies in the Line 1 population
would be similar to allele frequencies of the High EPD sires, and allele
frequencies of the Lents population would be similar to the Low EPD sires. This
expectation was not observed for any of the seven polymorphisms genotyped.
No significant differences in allele frequencies between the High and Low EPD
sires were observed. One reason for this may have been the limited number of
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sires representing each group (n = 13 and 14). Pooling the two EPD groups was
done so that a larger sample of sires representing the Hereford breed as a
whole could be used in comparisons with the Lents and Line 1 populations.
An important unknown factor when considering the effects of selection on
specific allele frequencies is the genetic background in which the frequencies
occur. Even though all three populations involved in this study represented the
Hereford breed, results clearly show that differences in allele frequencies exist
among the populations. Therefore, a favorable allele for growth in one
population may be unfavorable in other populations due to interactions of the
allele with background genes.
Genetic drift is another factor which may influence allele frequencies.
Genetic drift is a random process. and may eventually lead to the fixation of any
allele. The fixation of a more common allele at a particular locus is more likely,
but the fixation of an allele originally present at a low frequency is also possible.
Because this study determined genotypes for only one generation, changes in
allele frequencies within populations over time cannot be known. and effects of
genetic drift cannot be determined. However, differences in allele frequencies
observed at the B-Lac polymorphism may represent changes due to genetic drift.
At this polymorphism. the A allele was more common in the Line 1 population,
the B allele more common in the Lents population. and frequencies in the pooled
EPD population were intermediate between the Line 1 and Lents populations.
One possible explanation is that original frequencies of Line 1 and Lents
populations were similar to the pooled EPD popUlation. but genetic drift has led
toward fixation of the A allele in the Line 1 population, and fixation of the B allele
in the Lents population.
Changes in allele frequencies due to genetic drift may have been
amplified in the Line 1 and Lents populations because of inbreeding which
109
accumulated in those herds. Both the Lents and Line 1 are closed. relatively
small populations. Because of limited numbers of animals in the populations.
the mating of related animals could not be avoided completely. As a result, the
effective population size of the herds decreased and inbreeding accumulated,
causing a reduction in the pool from which gametes of the next generation were
obtained. As the gametic pool decreased. the chance of obtaining gametes for
the next generation with different allele frequencies from the preceeding
generation increased, increasing the possibility of random genetic drift.
Migration may be another cause of changes in allele frequencies. The
Line 1 and Lents populations have both been maintained as closed populations,
meaning no new germplasm has been introduced to the herds since they were
first established. In contrast, the pooled EPD population represents several
diverse genetic lines that have developed within the Hereford breed since the
Line 1 and Lents populations have been closed. Four of the sires included in
the pooled EPD population are polled, indicating a wide range of genetic lines
within the Hereford breed are represented. As these lines have developed,
factors previously discussed may have caused allele frequencies to differ among
the lines. The pooled EPD population represents many of these different lines
which have not influenced the Line 1 or Lents populations. Observed
differences in GH allele frequencies may represent changes due to migration of
different germplasm into the pooled EPD population that is not present in the
Line 1 or Lents populations. The B allele of the GH gene was more common in
the Line 1 and Lents populations. but the A allele was more common in the
pooled EPD popUlation. This could indicate that the A allele has recently
become more common in the Hereford breed because of its prevalence in lines
that are currently popular. whereas the B allele is more common in older lines.
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This result was unexpected because the Line 1 population has had a significant
impact on the Hereford breed.
A similar situation would exist if the animals which were used as the
foundation of the different populations, specifically Line 1 and and Lents, had
different allele frequencies. If these allele frequencies have not been
significantly changed over time, then different allele frequencies would be
observed in the present populations. Allele frequencies at the B-Lac and IGF-I
polymorphisms were significantly different between the Line 1 and Lents
populations, and may represent differences in allele frequencies of the founder
animals of these populations.
Mutation is a potential cause of differences in allele frequencies, but has
likely not been a factor in this situation. The polymorphisms genotyped in this
study are polymorphisms that are known to exist in other populations. In order
for mutation to have influenced observed allele frequencies, a point mutation or
deletion changing one allele to the exact sequence of the alternative allele must
have occured. The probability of this happening is negligible.
Finally, the numbers of animals representing each population of this study
need to be considered. The Line 1 population was represented by ....420
animals, the Lents population by 58, and the pooled EPD population by 24. One
problem with Chi-square test statistics is that they can be sensitive to small
expected values. and small expected values (less than five) were predicted in
several analyses. Bootstrapping (Weir. 1990) may be a more appropriate
method of analyzing these data. Bootstrapping operates by drawing random
samples of the same size as the original sample from that sample, and then
providing confidence intervals for allele frequencies. Significantly different allele
frequencies could then be determined by non-overlapping confidence intervals.
III
Differences in Heterozygosity
The primary effect of inbreeding is to increase the probability that
offspring will inherit the same allele from its sire and dam, thus lowering the
percentage of heterozygotes in the population (Lush, 1945). Therefore, it was
expected that the Lents population. which has the highest level of inbreeding.
would have the lowest percentage of heterozygotes (HI). and the pooled EPD
population, which has the lowest level of inbreeding, would have the highest HI.
These expectations were observed at the IGF-I. PRL. BM2113 and PIT1
polymorphisms. Expectations were not observed at the K-Cas (lowest HI
observed in Line 1). B-Lac (equal HI observed in Line 1 and pooled EPD) or GH
(highest HI observed in Lents) polymorphisms. However, inbreeding refers to all
of the genes of an animal, not specific loci.
The inbreeding coefficient (f) measures the percentage of genes which
were heterozygous in the base population but have become homozygous
because of inbreeding. Using the HI of the pooled EPD population as the basic
population, a decrease of 50% in the Lents population (f=.50) and a decrease of
30o~ in the Line 1 population (f=.30) would be expected. The average HI of the
Lents and Line 1 populations actually decreased by 59% and 26°~. respectively.
relative to the HI of the pooled EPD population. Thus, the average HI from all
seven polymorphisms closely reflects the decrease in heterozygosity that is
expected due to inbreeding. even though some individual polymorphisms fail to
meet expectations.
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Expectations of Hardy-Weinberg Equilibrium
In the Line 1 population, B-Lac, GH and PIT1 alleles appear to be
segregating as predicted for a population in Hardy-Weinberg equilibrium,
despite violation of many of the associated assumptions. IGF-I genotype
frequencies display some increase in homozygosity, while K-Cas genotype
frequencies illustrate the expected effects of inbreeding for a population in
Hardy-Weinberg equilibrium. In the Lents population, K-Cas alleles appear to
be segregating as predicted for a population in Hardy-Weinberg equilibrium, but
there is a significant increase in heterozygosity at the GH polymorphism. This
latter result is exactly opposite of what is expected when considering the high
level of inbreeding in the Lents population. However, if the less common A allele
is undergoing a process (selective or random) toward fixation, then selection of
AA and AS genotypes would be advantageous.
The conformity to Hardy-Weinberg equilibrium expectations in these
populations was surprising because the Line 1 and Lents populations are
relatively small (n= 420 and 58, respectively), mating was not random, i.e, a
limited number of sires were selected for the next generation, and selection for
increased growth was practiced in the Line 1 population. These are all
violations of assumptions associated with the Hardy-Weinberg equilibrium
theory (Falconer, 1989). The differences that were observed when comparisons
were made using expected values that had been adjusted for inbreeding were
also surprising because results from the previous section indicated that the
amount of heterozygosity had decreased as expected for the amount of
inbreeding in each population. However, results from the previous section
considered average HI, which included all seven polymorphisms studied, while
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comparisons to expectations of Hardy-Weinberg equilibrium could only be done
for individual loci. Perhaps the most unusual result was the significant increase
of heterozygotes observed for the GH polymorphism in the Lents population.
The explanation for this observation is unclear, but the A and B alleles of the GH
polymorphism do represent different forms of the GH protein that differ in their
amino acid sequence. Therefore, a physiological selective advantage to the
production of both forms of GH may exist, and this may cause a natural selective
advantage for the AS genotype of GH in the Lents population.
Part II: Associations Between DNA Polymorphisms and
Growth and Maternal Traits
Potential Genetic Markers
Before DNA polymorphisms can be considered as potential markers of
QTL, some basic differences in types of polymorphisms must be understood. In
this study, the K-Cas, B-Lac and GH polymorphisms result from point mutations
in one allele of their respective genes. When translated, the two different alleles
of each of these loci code for different forms of each protein. which differ in their
amino acid sequence. The different amino acid sequences of the protein
products may cause different physiological effects for responses to the protein.
This difference in physiological response could then have a significant effect on
a quantitative trait. Therefore. genotypes determined at these loci identify
different protein products which have the potential of directly influencing a
quantitative trait through different physiological responses to differences in
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amino acid sequences. In addition, these genotypes may be used as markers of
the chromosomal region in which they are located.
IGF-I and PIT1 polymorphisms also serve as markers of chromosomal
regions, but are not translated to different protein products. DNA polymorphisms
that serve as markers of chromosomal regions enable the inheritance of that
region to be monitored from parent to offspring. This allows for possible
associations between the chromosomal region and effeds on quantitative traits
to be identified by comparing offspring which inherited one allele to offspring that
inherited an alternative allele. In this situation, the cause of the effect may not
be the marker itself, but polymorphisms in other genes (QTL) closely linked to
the marker. However, the possibility that the effect is caused by the gene
containing the marker is not eliminated. Before markers may be used in a
marker assisted selection program, it is necessary to understand the linkage
phase, or the linkage relationship between the marker and the QTL causing the
effect. For example, the A allele of the marker may be linked to the favorable
allele of the QTL in one family, but linked to the unfavorable allele of the QTL in
another family. This linkage phase may also change within families due to
recombination events that take place between the marker and QTL. The chance
of a recombination event changing the linkage phase within a family decreases
with closer linkage between the marker and QTL. In order to identify effects of
marker polymorphisms on quantitative traits, and to determine their linkage
phase, marker polymorphisms must be analyzed within large families whose
chromosomes are segregating at the marker locus. Otherwise, significant
effects associated with a chromosomal region may not be detected because of
differences in linkage phase among families.
Milk Production. Based on the regression analysis of EPD data, the effect
of allele substitution on MILK EPD for the K-Cas, GH and IGF-I polymorphisms
lIS
was significant. These results indicate that these polymorphisms may be
markers of QTL involved in milk production. In addition, it is possible that the
polymorphisms in the K-Cas and GH genes may have direct effects on milk
production.
Despite significant effects of allele substitution, the magnitude of effect
was small for GH and IGF-I polymorphisms. The percentage of variability in
MILK EPD explained by genotype was 1.66% for GH and 2.88% for IGF-1. In
contrast, K-Cas genotype accounted for 11.33% of the variability in MILK EPD.
The mean MILK EPD for cattle of K-Cas genotype AA was 6.2 pounds greater
compared to cattle of K-Cas genotype BB. Because of this relatively large
effect, the K-Cas polymorphism deserves further attention to investigate its
usefulness as a genetic marker for milk production in a marker assisted selection
program.
Several studies have investigated the effects of the K-Cas and B-Lac
polymorphisms on milk yield in dairy cattle, and many conflicting results have
been reported for the effect of K-Cas genotype. Significant advantages to milk
production from the K-Cas A allele have been reported (Bovenhuis at aI., 1992;
Gonyon at aI., 1987; Ng-Kwai-Hang et aI., 1986), which are consistent with the
results from the present study. However, others have reported significant
advantages to milk production from the K-Cas B allele (Cowan et aI., 1992; Van
Eenennaam and Medrano, 1990; Lin et aI., 1989), and still others found no
signifcant effect of K-Cas genotype on milk yield (Aleandri at aI., 1990; Ng-Kwai-
Hang et aI., 1990). Possible explanations for these discrepancies include
differences in statistical models, differences in the type of milk yield data
analyzed, and differences in populations. Another likely explanation is that the
observed effect is not a direct result of the K-Cas polymorphism, but the
polymorphism is acting as a marker for a linked QTL influencing milk production.
116
Bovenhuis et al. (1992) showed that the K-eas gene was linked to the p-casein
gene in the Dutch dairy cattle population. and that a significant effect of K-Cas
genotype on milk production was actually due to the p-casein gene. This result
was confirmed by a later study (Bovenhuis and Weller, 1994). Cowan at at
(1992) concluded that the inconsistencies reported for the effect of K-Cas
genotype on milk yield suggest that the linkage phase between K-Cas and QTL
influencing milk yield differs among populations. This is the first report of the
effects of K-Cas genotype on milk production in beef cattle.
Studies of the effects of B-Lac genotype on milk yield report a significant
advantage for the B-Lac A allele (Bovenhuis at al.. 1992; Cowan at al.. 1992,
Aleandri at aI., 1990; Ng-Kwai-Hang at ai., 1986; Geldermann at aI., 1985),
which was also observed in the present study. Consistencies among these
studies indicate that B-Lac may have a direct effect on milk yield. Nevertheless,
other studies have failed to determine a significant association between B-Lac
genotype and milk yield (Van Eenennaam and Medrano, 1991; Ng-Kwai-Han at
al.. 1990; Lin et aI., 1989; Hanlein et aI., 1987; Gonyon at aI., 1987).
Ziehe et al. (1993) considered the effects of K-Cas and B-Lac
polymorphisms on milk production and calf performance in Angus and Polled
Hereford sired beef heifers. A significant advantage of the K-Cas A allele on
milk production during early lactation, and on calf weaning weight was reported
for Angus-sired heifers, which is consistent with results of the present study.
However, no heifers with the K-Cas BS genotype were included in the study and
a similar effect was not observed in Polled Hereford-sired heifers. No significant
genotype effect was observed for the B-Lac polymorphism, but only the AB and
BB genotypes were represented. The actual role of K-Cas and B-Lac genotype
in milk production remains unclear. As results of studies which evaluate these
effects in different populations are published, perhaps the role of these genes in
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milk production will become better understood. However, it does appear clear
that K-Cas is a QTL or is closely linked to a QTL for milk production.
Birth Weight. Based on the regression of BWT EPD on genotype, the
effect of allele substitution was significant for the K-Cas, B-lac, IGF-I and PIT1
polymorphisms. Results from the regression of BWT phenotypic data on
genotype confirmed significant effects of allele substitution for the K-Cas, B-Lac
and IGF-I polymorphisms. These results suggest that K-Cas, B-Lac and IGF-I
polymorphisms may be markers of QTL influencing birth weight in this
population. K-Cas and IGF-I genotypes are likely to be more useful markers of
BWT EPD because they explained 9% and 6%, respectively, of the variability in
BWT EPD compared to 2% of variability explained by B-Lac genotype. K-Cas,
B-Lac and IGF-I explained 1.5%, 1.0% and 0.8%, respectively, of the total
variation in birth weight phenotype, suggesting effects of similar magnitude from
the three polymorphisms.
Weaning Weight. Based on the regression of WWT EPD on genotype,
the effect of allele substitution was significant for the K-Cas and IGF-I
polymorphisms. Regression of 200-day weight on genotype confirmed the
significant effect of K-Cas. However, the magnitude of the effect of K-Cas was
small, explaining 2% of the variability in WWT EPD and .6°~ of the total
varaibility in 200-day weight. Because of this small magnitude of effect. the use
of ·K-Cas genotype as a marker for weaning weight in a marker assisted
selection program may not be practical.
Yearling Weight. Regression ofYWT EPD on genotype indicated a
significant effect of allele substitution for the K-Cas polymorphism. The
magnitude of the effect was small, explaining only 2% of the variability in YWT
EPD. Regression of 365-day weight on genotype failed to confirm a significant
association between K-Cas genotype and yearling weight. Because of the small
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magnitude of effect on YWT EPD, and the lack of significant effed on 365-day
weight, the K-Cas polymorphisms should not be considered a marker of QTL
influencing yearling weight without confirmation from additional studies.
However, the effects of K-Cas genotype on WWT and YWT EPD may indicate
that K-Cas is linked to a gene influencing growth in general in this population.
Statistical Analyses
Regression Analysis. Results from the regression analyses of EPD and
phenotypes on genotype were similar; all significant gene effects were additive
in nature. In general, lower significance levels were observed from analyses
using phenotypes compared to analyses using EPD. These minor differences
between analyses were not unexpected. Analyses using EPD as the dependent
variable considered the effects of genotype on additive genetic effects. as
estimated by EPD. Analyses using phenotypes as the dependent variable
considered the effects of genotype on phenotype, which is influenced by
additive, dominant and epistatic gene effects, as well as environment. Error in
the analyses using phenotypes may have been inflated by fixed effects that were
unaccounted for, and by non-additive genetic variation at loci other than those
genotyped. Therefore. regression analysis of EPD is likely more informative in
estimating effects of DNA polymorphisms on additive gene action.
The percentage of variability of EPD. the percent of total variability in
phenotype, and the percent of residual variability in phenotype remaining after
variability due to sire, year, sex and age of dam were removed were low (2% and
less) for several effects that were detected as significant (K-Cas genotype on
weaning and yearling weight, B-Lac genotype on birth weight, GH genotype on
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MILK EPD, and PIT1 genotype on birth weight). Because of the relatively small
population size used in this study, the statistical power of the analyses was
probably not great enough to detect such small effects. The fact that these small
effects were detected as significant indicates the results may be spurious. Two
significant results would be expected by chance from the 35 analyses included
in the EPD regression and Regression model 1 analyses at a 5% significance
level. Therefore, significant results haVing small magnitudes of effects should
be interpreted with caution until they can be confirmed or rejected by additional
studies.
When sire was included as a fixed effect in the analyses of phenotypes.
the only significant effect observed was the effect of B-Lac genotype on BWT.
The effect of sire was significant in all analyses, accounting for a large portion of
the phenotypic variability. Some of this phenotypic variability that was
accounted for by sire may have resulted from the genotype of the sire that was
passed on to his offspring. A more appropriate analysis would be to analyze the
effects of genotype within sire families. Unfortunately. the small numbers of
animals within half sib families of heterozygous sires prevented this analysis
from being informative for this population.
Least Squares Analysis. Results from the least squares analysis were
similar to results from regression analysis. This was expected due to the similar
nature of the two analyses. The effect of B-Lac allele substitution on BWT
phenotype from regression analysis was significant with and without sire
included in the model as a fixed effect. However, least squares analysis failed to
reveal significant effects for these analyses. Significant interactions for B-Lac x
age of dam and B-Lac x year were observed through least squares analysis.
These interactions were not included in regression analyses and may have
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influenced those results. Other minor differences resulted from a decrease of
significance level in the least squares compared to regression analyses.
Animal Model. Kennedyet al. (1992) suggest that ordinary least squares
analysis may result in finding an excess of spurious significant effects of single
genes when no effect exists. The bias of the analysis is diredly proportional to
the heritability of the polygenes influencing the trait, and increases with
increasing selection intensity. Kennedy et al. (1992) show that the use of mixed
model equations under an animal model with single-locus genotype treated as a
fixed effect results in unbiased estimates of the genotype effed.
The phenotypic data in the present study were analyzed using an animal
model, and linear contrasts were calculated to determine additive and
dominance gene effects. Unlike the other models which considered the effects
of each locus individually, the animal model tested the effect of each locus with
all genotypes included in the model. Even though the five polymorphisms
segregated independently due to their locations on different chromosomes, the
possibility of interactions resulting from epistatic effects remains. Results from
the animal model analysis indicated no significant effects of genotype on growth
traits in the Line 1 population, which is in agreement with regression and least
squares results when sire was included in the model as a fixed effect.
The implications of these results are not clear. The animal model
analysis is designed to adjust for relationships among animals and provide
estimates of the additive genetic merit of individuals. Therefore, results from the
animal model analysis were expected to be similar to regression and least
squares analyses using EPD data. The most likely cause for the discrepancies
of results is the size of the population involved in the study. A total of 395
animals had complete genotype and phenotype records to be analyzed using the
animal model, which is designed to be used with much larger data sets. The
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number of animals involved in this study limited the power of the animal model
analysis and may have prevented the detection of significant effects. Another
possibility is that there simply were no significant effects of genotype on the
traits analyzed. Significant effects of genotype on WWT EPD and YWT EPD
were observed from regression analysis, but the small magnitude of these
effects «2% of variability explained) cause the validity of these results to be
questionable. In addition, significant associations between genotype and 365-
day weight phenotype were not observed.
In contrast to the effects of genotype on weaning and yearling weights,
the magnitude of effects of K-Cas. B-Lac, IGF-I and PIT1 genotype on birth
weight were larger (1-9% of 8WT EPD variability explained). Significant effects
of K-Cas, B-Lac and IGF-I genotype on 8WT phenotype were also observed,
which further supports the validity of the results. However. the lack of significant
effects of genotype on 8WT EPD and phenotype resulting from the animal
model analysis cannot be overlooked completely. Further investigation involving
larger populations will be needed in order to better understand the actual effects
of these genotypes on birth weight.
Limitations
Population Size and Structure. The fields of marker assisted selection
and molecular genetics applied to the improvement of livestock are still being
explored and established. Several different approaches have been taken to
investigate associations between DNA markers and quantitative traits in cattle
(Georges et aI., 1993; Andersson-Eklund and Rendel, 1993; Ziehe et aI., 1993;
Rocha et aI., 1992; Hoj et aI., 1992; Bovenhuis et aI., 1992). A common obstacle
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faced by each study was the identification of informative populations in which to
study the effects of DNA markers. It has been suggested that several thousands
of animals would be required to detect a OTL accounting for additive genetic
variance equal to 1% of total phenotypic variance at 90% power (Soller and
Genizi, 1978). However, the accuracy of these estimates remain to be proven
experimentally. Pomp at al. (1994) detected markers linked to four OTL for body
weight and fat in mice which accounted for 1 to 2% of the total phenotypic
variation, and one marker which may be linked to a pleiotropic OTL with larger
effects. A total of 424 animals were genotyped in the study, which is much less
than the predicted number of animals (Soller and Genizi. 1978) required to
achieve those results. In pigs, Andersson et al. (1994) identified a region of
chromosome 4 that accounted for a large portion of variation in growth rate and
fatness. A total of 200 F2 offspring of a cross between the European wild boar
and the domesticated Large White pig were involved in the study. Rothschild et
al. (1994) successfully identified a polymorphism having a major effect on litter
size in pigs based on 85 first parity records. In all of these studies. the
populations utilized were carefully designed in order to maximize the probability
of identifying a OTL. Examples such as these indicate that the proper design of
populations may enable OTL to be identified from many fewer animals than
originally suggested by Soller and Genizi (1978).
The present study considered a very unique population, which presented
both advantages and disadvantages to the project. The Line 1 population has
undergone 60 years of selection for increased growth (MacNeil et aI., 1992).
Selection is successful because it increases the frequency of favorable alleles
and decreases the frequency of unfavorable alleles that influence the trait being
selected. Therefore, some OTL which have large effects on growth traits may
have become fixed for favorable alleles, while unfavorable alleles may have
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been eliminated from the Line 1 population. The variation in growth traits that
does remain in the Line 1 population is probably due to several loci that each
contribute a small effect to growth traits. Because of this, the identification of a
marker for growth traits may be more difficult in the Line 1 population than in a
non-selected population. However, the Line 1 population offered the advantage
of having data available for growth traits of all ancestors in the population.
These data increased the accuracy of the predictions of EPD and were useful in
the animal model analysis.
The Line 1 population is also unique because it has been closed to the
introduction of outside germplasm, accumulating an average inbreeding
coefficient of approximately .30 (MacNeil at aI., 1992). This indicates that the
genetic background among animals in the Line 1 population is very similar. A
homogeneous genetic background is desirable, as long as variation exists at
polymorphisms being studied, because interactions among markers and the
genetic background would be similar among animals. Effects from background
genes are less likely to be a source of variation in an inbred population
compared to a non-inbred population.
The structure of a population used for this type of study is also an
important consideration. An F2 backcross or intercross population from two
genetically distinct lines (Barinaga, 1994) is perhaps the "ideal" population in
which to identify DNA markers of QTL. This type of population can be
developed in laboratory animals and livestock species with short generation
intervals, but it is a time-consuming and expensive process in cattle. The
granddaughter design (Weller et aI., 1990), which involves genotyping
grandsires and sons, and analyzing phenotypic data from granddaughters, has
been employed in studies of milk composition and production traits in dairy cattle
(Cowan et al., 1992). This design reduces the amount of genotyping required
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(Weller et al.. 1990). but requires phenotypic data from large numbers of
granddaughters from grandsires that must be heterozygous for DNA markers
evaluated.
The Line 1 population was made up of several small half-sib families
representing 24 sires. Because of the limited number of offspring from each
sire, the data could not be analyzed within sire families. Therefore, the effect of
alternative alleles from a heterozygous sire could not be determined. One of the
limitations of this study is that it is not known if effects associated with K-Cas. B-
Lac and GH polymorphisms are due to a direct biological effect caused by
differences in proteins produced by alternative alleles, or if the polymorphisms
act as markers of a chromosomal region containing QTL influencing the traits of
interest. The structure of the Line 1 population prevents investigation to
determine if observed effects are due to a direct or marker effect of the
polymorphisms. Large segregating families in which the effects of alternative
alleles could be followed from parent to offspring would be required in order to
better understand the nature of the observed effect.
A final characteristic of the Line 1 population that deserves consideration
is the genotypic frequency of each polymorphism. Both A and B alleles were
segregating for five of seven polymorphisms genotyped in the population, but
the PIT1 AA genotype was represented by only eight animals. If these eight
animals had extreme values for the phenotypic traits analyzed, results of the
analysis would be biased. Weighting of analyses for genotypic frequencies was
done to avoid such bias, but resulted in large standard errors from genotypic
classes with low frequencies. The use of markers with equal allele frequencies
would help to avoid this problem because genotypic classes would less likely be
represented by few animals with extreme values that may not be truly
representative of the actual mean of the genotypic class.
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Applications to Marker Assisted Selection Programs. The most important
result from this study was the identification of the effect of K-Cas genotype on
MILK and BWT EPD. These effects were statistically significant and accounted
for a large portion of the variability in EPD. However, due to the limitations of
this study, these results do not mean that selection for decreased birth weight or
increased milk production should be based on K-Cas genotype. Instead, they do
indicate that K-Cas deserves further attention as a potential marker of these
traits.
Several considerations must be made before any DNA marker is
incorporated into a selection program. First, the true effect of a polymorphism
must be clearly understood. Markers which have a direct biological effect on the
traits they influence should be expected to have a consistent effect in different
families of similar genetic background, whereas the effects of markers which are
linked to genes or QTL influencing a trait will depend on the linkage phase
between the marker and QTL. The linkage phase between a marker and a QTL.
the closeness of linkage between a marker and a QTL, and the magnitude of
effect attributable to a marker should be understood for a marker in the genotype
and physical environment in which it is to be used. The present study identified
the K-Cas A allele as favorable for MILK EPD and the B allele as favorable for
BWT EPD, and estimated the magnitude of each effect. However, further study
is required to understand the cause of these effects and how K-Cas might be
used in a marker assisted selection program.
It must also be considered that results of one study may be limited to the
genetic environment in which they were obtained. In this example, the Line 1
Herefords are a very unique population because of selection pressures that
have been placed on the herd and the amount of inbreeding that has
accumulated. Associations between DNA polymorphisms and growth and
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maternal traits that were identified in this study may be very different in a
different genetic background. The effed of K-Cas genotype on milk produdion
and protein percentage is an example of a marker that appears to have different
effects in different populations (80venhuis et aI., 1992). Even within the Holstein
breed, Cowan et al. (1992) reported opposite effects of K-Cas alleles on protein
percentage in two different families. The K-Cas example provides an important
warning that selection based on a genetic marker should not be promoted until
the effects of the marker are fully defined.
Finally, correlated responses due to marker selection for a specific trait
cannot be overlooked. In this stUdy. K-Cas and IGF-I polymorphisms had
significant effects on both MILK and 8WT EPD. The addition of a B allele
affected both traits in the same direction indicating that selection for increased
maternal ability would also result in an increase in birth weight. This is an
undesirable correlation in many situations and should be considered before
using these markers in a marker assisted selection program. In contrast, the GH
polymorphism had a significant effect on MILK EPD but no effect on 8WT EPD,
while B-Lac genotype had a significant effect on 8WT EPD but no effect on
MILK EPD. Thus, GH may be a useful marker when the selection goals are to
increase maternal ability without increasing birth weight and B-Lac may be a
useful marker to achieve a decrease in birth weight without sacrificing maternal
ability. The response in 8WT EPD and MILK EPD to K-Cas and IGF-I is only
one example of a possible correlated response to marker assisted selection.
Many other correlated responses, both desirable and undesirable, may exist and
should be considered before genetic markers are included in selection
programs.
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Potential for Future Research
The most definitive conclusion that can be drawn from this study is that
more research is needed if the effects of DNA polymorphisms on quantitative
phenotypic traits are to be understood and used as selection criteria in marker
assisted selection programs. At the time this project was initiated, bovine gene
maps had not yet been developed. For that reason. the candidate gene
approach was used to identify genes whose protein products were known to
have a biological effect on growth and maternal traits as potential markers of
these traits. Success of this approach has recently been documented in pigs
(Rothschild et aI., 1994)
The development of the bovine genetic map (Barendse at aI., 1994;
Bishop at aI., 1994), more efficient experimental designs (Weller et aI., 1990)
and the refinement of statistical techniques to accommadate molecular data
(Lander and Botstein, 1989; Zeng, 1993; Jansen, 1993; Haley et al., 1994; Zang,
1994; Jansen and Starn, 1994) now allow for more sophisticated strategies to be
employed in order to identify regions of the genome that are associated with
quantitative traits. Several studies in mice have utilized murine genetic linkage
maps to select markers distributed throughout the genome in order to identify
QTL influencing quantitative traits (Berretini et aI., 1994; Pomp et aI., 1994;
Warden et at, 1993). Although the bovine map is not as saturated as the
murine map, the same type of approach may now be used in cattle. Results
from previous projects using the candidate gene approach will be useful to future
research in order to target specific regions of the genome to study. For
example, the polymorphism in the K-Cas gene, which has been mapped to
bovine chromosome 6, was found to have a significant effect on BWT EPD in the
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Line 1 population. Future studies may begin by choosing other polymorphisms
linked to K-Cas on chromosome 6 in order to identify a marker more closely
associated with a QTL influencing birth weight. Similarty, chromosomes 6 and
11 may be logical starting points for the study of QTL influencing growth
because these chromosomes harbor K-Cas and IGF-I polymorphisms.
respectively, which were identified as having significant effects on weaning
weight. Ideally, a more efficient approach will be to utilize the genetic map first
to identify regions of the genome having an effect on a QTL, and then use the
candidate gene approach to investigate genes located within that region in order
to identify the specific gene responsible for the effect.
Another source of information to consider is the identification of
chromosomal regions which affect quantitative traits in other species, for
example mice or pigs. As more Type I markers are added to genetic maps, it will
become possible to identify homologous chromosomal regions between cattle
and other species. If QTL influencing quantitative traits are located in
homologous chromosomal regions in different species, then the identification of
QTL in mice or pigs could be helpful in identifying QTL for the same traits in
cattle. For example, Pomp et al. (1994) identified a QTL influencing body weight
and fat percentage on chromosome 2 in mice. Other genes located in the same
region of mouse chromosome 2 have been mapped to bovine chromosome 13.
Therefore, markers on bovine chromosome 13 would be logical choices for
investigation of markers of QTL influencing growth or fatness in cattle. In pigs,
Andersson at al. (1994) identified a QTL influencing growth and fatness located
on chromosome 4. Unfortunately, no Type 1 markers are present on
chromosome 4 of the current porcine genetic map (Rohrer et aI., 1994), so a
homologous region in the bovine genome cannot yet be identified. This
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emphasizes the need for more Type 1 markers to allow for the comparison of
genetic maps across species.
Although the identification of DNA markers linked to QTL is an essential
step in the process of making MAS a reality, it is not the final step. Markers of
QTL define pieces of a genetic puzzle. The next step will be to put those pieces
together. In doing this, it will be important to keep in mind that complete animals
with complex genomes will ultimately be selected. Just as the phenotypic
performance of an animal is influenced by the environment, the performance of a
specific genotype will also depend on the genetic and physical environment in
which it is expressed. It should be emphasized that the goal is marker assisted
selection, not marker based selection. DNA markers will not replace information
gained from performance testing and phenotypic appraisal, but DNA markers will
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APPENDIX 1
DNA Extraction from Blood Samples:
Salt Extraction Protocol
Solutions
Red Blood Cell (RaCl Lysis Buffer
.017 M Tris
.14 M NH4CI
For 1 liter of 1X RBC lysis buffer:
17.0 ml1M Tris (pH 7.65)
7.49 9 NH4CI
Dilute in water for a total volume of 1 liter.
Warm to 37°C in water bath before use.
Nuclei Lysis Buffer
.01 M Tris-HCI pH 8.0
.4 M NaCI
.002 M EDTA pH 8.0
For 1 liter of 1X Nuclei Lysis Buffer:
5.0 ml2M Tris-Hel pH 8.0
80.0 ml 5M NaCI
4.0 ml.5 M EDTA pH 8.0
Dilute in water for a total volume of 1 liter.
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TE (pH 8.0)
10 mM Tris-HCI (pH 8.0)
1 mM EDTA (pH 8.0)
For 1 liter of 1X TE:
1.576 9 Tris-HCI
.372 9 EDTA
Dilute in water for a total volume of 1 liter.
Other Reagents Needed
• .15 M NaCI • 6M NaCI (saturated salt solution)
• 10% 50S • Iso-propanol
• Proteinase-K (20 mg/ml) • 70% ethanol
Procedure
1. Centrifuge blood tubes at 2000 rpm for 10 minutes at 4°C, accelerate 8,
decelerate 8.
2. Aspirate off plasma using a transfer pipet; discard (optional).
.3. Carefully pull off buffy coat plus any red blood cells that tag along using a
transfer or glass pipet. Place in a 15 ml centrifuge tube and add 370C
RBC Lysis Buffer to bring volume to 14.5 mi.
4. Incubate at 370C for 10 minutes.
5. Centrifuge at 2000 rpm for 10 minutes at 4°C, accelerate 8, decelerate 8.
6. Pour off supernatant and blot tube upside down on kimwipe.
7. Resuspend pellet in 5.0 ml of .15 M NaCI.
8. Centrifuge at 2000 rpm for 10 minutes at 4°C, accelerate 8, decelerate 8.
ISS
9. Repeat steps 6 and 7 if needed to remove red blood cells.
1O. Pour off supernatant and blot tube upside down on kimwipe. Resuspend
pellet in 4.0 ml of Nuclei Lysis Buffer (be sure to resuspend pellet before
adding 50S). Add 300 I.d of 10% 50S and 50.0 J.l1 of Proteinase-K (20
mg/ml) and incubate 1 to 3 hours with shaking at 600C.
11. Samples should be a thin, runny liquid at this point. If not, add 50.0 J.l1 more
Proteinase-K and incubate with shaking for an additional hour at 60oC.
Let samples cool at room temperature for 10 minutes.
12. Add 1.3 ml of saturated salt solution (6M NaCI) and shake vigorously for 15
seconds. Let stand at room temperature for 5 minutes.
13. Centrifuge at 2700 rpm for 10 minutes at 40C. accelerate 8, decelerate 8.
14. Draw off supernatent into another 15 ml centrifuge tube and add an equal
volume of Iso-propanol. Gently rock the tube until DNA precipitates (it
should look like white or clear angel hair). Remove DNA with a curved
glass pipet hook. Rinse with 70% ethanol.
15. Place pipet in a 1.5 ml tube and dry in vacuum oven (no heat) for 2-12
hours. Resuspend in 500 JlI TE buffer.
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10 mM Tris-HCI (pH 8.0)
1 mM EDTA (pH 8.0)
For 1 liter of 1X TE:
1.576 9 Tris-HCI
.37224 9 EDTA
Dilute in water for a total volume of 1 liter.
Other Reagents Needed
• Proteinase-K (20 mg/ml)
• DTT (1 M in 10 mM NaAc)
• Tris buffered phenol
• 3 M sodium acetate (NaAc)
• 100% ethanol at -20oC
• 70% ethanol
IS7
• Tris buffered phenol/chloroform:iso-amyl alcohol
• Chloroform: iso-amyl alcohol
Procedure
1. Empty entire straw or transfer .5 ml from ampule of bull semen into a 2.0 ml
microcentrifuge tube. Add 1 ml ddH20, mix briefly, then centrifuge at
8000 rpm for 5 minutes to pellet the sperm.
2. Carefully pour or aspirate off the supernatant, being careful not to disturb the
pellet. If floating milky substance sticks to the inside of the tube, remove
it with a sterile cotton swab being careful not to touch the pellet with the
swab.
3. Resuspend the pellet in 750 JJI of STES digestion buffer and mix well.
4. Add 15 III of Proteinase-K and 40 ).11 of OTT and mix by rocking back and
forth. Incubate overnight at 370C or 1 to 3 hours at 60°C.
5. Add 750 J.11 of Tris buffered phenol. Put samples on rotator or mix back and
forth by hand 5 minutes (be sure caps are securely closed).
6. Centrifuge for 5 minutes at 3000 rpm.
7. Transfer the top aqueous phase into a new 2 ml microcentrifuge tube. Add
TE to restore volume to 750 J.11. Add 750 ).11 of Tris buffered
phenol/chloroform: iso-amyl alcohol and mix by rocking for 5 minutes.
8. Centrifuge for 5 minutes at 3000 rpm.
9. Transfer the top aqueous phase into a new 2 ml microcentrifuge tube. Add
TE to restore volume to 750 I.d. Add 750 III of chloroform: iso-amyl alcohol
and rock for 5 minutes to mix.
1O. Centrifuge for 5 minutes at 3000 rpm.
11. Transfer the top aqueous phase into a 2 ml tube, note volume, then pour
into a 5 ml Falcon tube.
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12. Add 1/10 volume of 3 M NaAc, cap tubes and mix well by rocking back and
forth.
13. Add 2 volumes of -20oC 100% ethanol and rock back and forth until DNA
precipitates (it should look like white or clear angel hair). Remove DNA
with a curved glass pipet hook. Rinse with 70% ethanol. Place pipet in a
1.5 ml tube and dry in vacuum oven (no heat) 2-12 hours. If no DNA is
visible, place tube in -80oC for one hour. Centrifuge at 10.000 rpm for 15
minutes at 4°C. Pour or aspirate off the supernatant and dry pellet in
vacuum oven.
14. If DNA was present in the previous step without centrifugation, then
resuspend in 200 J.l1 of TE. If centrifugation was necessary, then




5' , , , , , , , , , , , , , , 3'
3' ' , , , , , , , , , , , , , , , , 5'
5' I I I I I I I I I I I I I I I I I 3'
5' I I I I I I I I I I I I I I I I I 3'
3' , , , , , , , , I I I I ' , I I I 5'






, , , . , , , , , , , , , , · · · 3'5'3'
, I , ,
5'
~









Legend: 1. Denaturation of double stranded DNA template to two single strands.
2. Annealing of primers to complementary sequence of template DNA.
3. Extension of primers using Taq polymerase to make two double
stranded copies of the template DNA.
APPENDIX 4
Sample Calculations for Determining DNA Concentrations and Making
Working Solutions
DNA Concentration:
[DNA] J,lg/ml =(A260)(DF)(50 J,lglml)
where: A260= Absorbance of stock solution at 260 nm
OF =dilution factor
50 Jlg/ml = constant
Example:
A260 =0.100
OF =100 (10 III stock DNA diluted in 990 III water)
[DNA] 1l9/ml =(0.100)(100)(50)
=500 Jlg/ml
Working Solution: 200 J.11 of 50 ng/J.11 final concentration
(50 ng/lll)(200 Ill) =10000 ng of DNA needed
JlI of stock solution to add =(10000 n9) I [DNA] J.1Q/ml
(Note: ng/JlI =J-lg/ml)
III of TE to add =200 JlI - JlI of stock solution to add
Example:
J,ll of stock solution to add =(10000 ng) I (500 J,1g1ml)
=20 JlI of stock solution
J,ll of TE to add = 200 J,ll - 20 J,ll
=180 JlI of TE
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APPENDIX 5
Working Solutions for peR Primers from Lyophilized Oligonucleotides
Dissolve Oligonucleotides
1. Add 100 J.11 of PCR water to each tube of lyophilized primer. Leave tubes
undisturbed at room temperature overnight.
2. Vortex all tubes containing primer. Pulse-spin. Combine all tubes (4) for
each primer into one 1.5 ml microcentrifuge tube. This will be the stock
primer solution. Vortex and pulse-spin
Measure Absorbance
1. Place 998 JlI of water in a 1.0 ml cuvette and zero at a wavelength of 260 nm.
2. Add 2 III of primer from the stock solution, mix and record absorbance at a
wavelength of 260 nm.
3. This is a 1:500 dilution, and 400 - 2 =398 III of primer stock solution remain.
Dilution
1. Determine the volume necessary to dilute the primer stock solution to a final
concentration of 50 ~M:
A) From the primer information sheet, obtain the following values:
Jl9/OD
Molecular Weight
B) Calculate the 11M concentration of the primer stock solution:
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Jlg/ml =(OD260) (Dilution factor =500) (JlglOD)
ng/ml =(~g/ml) (1000)
JlM =(nglml) I Molecular Weight
C) Calculate the total volume for a 50 JlM primer stock solution:
total volume (J.1I) =[(J.1M stock) (JlI stock remaining)] I 50 J.1M
D) Calculate the volume needed to dilute the stock solution to 50 J,lM:
JlI to add =total volume (J.1I) - J.l1 stock remaining
E) Be sure to label stock solutions as either forward or reverse primer
2. Add the appropriate amount of PCR water to dilute the primer stock solution
to 50 J.1M. Remember. this solution contains a single primer, either
forward or reverse. This stock solution may be stored at -20°C.
3. Make 300 III of 5 IJ,M working solution. forward and reverse primer, for PCR:
30 ).11 of 50 J.1M stock. forward primer +
30 J.11 of 50 J.1M stock. reverse primer +
240 III of PCR water
4. Working solutions may be stored at -200C and are ready for use in PCR.
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APPENDIX6a
M13 DNA Sequencing Standard Protocol
Sequenase Version 2.0
(United States Biochemical Corporation, Cleveland, OH)
Equipment Needed: • Water bath at 650C • Heat block at 370C
• Water bath or PCR machine at eooc before loading
Thaw 33p in hood in designated area.
Thaw ingredients at room temperature, then place on ice:
• ddNTPs • DTT • Sequenase buffer
• -40 primer • dGTP labelling mix • Stop solution
• ssM13 DNA • Enzyme dilution buffer
Place sequenase on ice.
Label microcentrifuge tubes:
• Four .6 ml tubes labelled G, A, T, C. Labelling mix tube
• Reaction tube • Enzyme dilution tube
In Reaction tube, mix well on ice (for 1X reaction):
1 JlI -40 primer
2 JlI Sequenase buffer
7 JlI ssM13 DNA
10 J-li PCR water
• Heat reaction to 65°C for 4 minutes .
• Remove and incubate at room temp for 15-30 minutes
Labelling mix, mix well on ice:
4 J.11 dGTP labelling mix
16 JlI PCR water
Enzyme dilution, mix well on ice:
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APPENDIX 6a
M13 DNA Sequencing Standard Protocol
Sequenase Version 2.0
(United States Biochemical Corporation, Cleveland, OH)
Equipment Needed: • Water bath at 650C • Heat block at 370C
• Water bath or PCR machine at BOoC before loading
Thaw 33p in hood in designated area.
Thaw ingredients at room temperature, then place on ice:
• ddNTPs • on • Sequenase buffer
• -40 primer • dGTP labelling mix. Stop solution
• ssM13 DNA • Enzyme dilution buffer
Place sequenase on ice.
Label microcentrifuge tubes:
• Four .6 ml tubes labelled G, A, T. C. Labelling mix tube
• Reaction tube • Enzyme dilution tube
In Reaction tube, mix well on ice (for 1X reaction):
1 JlI -40 primer
2 JlI Sequenase buffer
7 ).11 ssM13 DNA
10 ).11 PCR water
• Heat reaction to 65°C for 4 minutes
• Remove and incubate at room temp for 15-30 minutes
Labelling mix, mix well on ice:
4 ~I dGTP labelling mix
16 J-li PCR water
Enzyme dilution, mix well on ice:
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2 J.11 Sequenase
14 III Enzyme dilution buffer
Termination tubes, place in 370C block to warm:
2.5 J.11 ddNTP (i.e., ddATP in tube A, ddGTP in tube G, etc.)
When Reaction has incubated at least 15 minutes at room temp., add in order:
1 III DIT
2 JJ.I Labelling mix
1 JlI 33p dATP
2 J.1I Diluted enzyme
• Incubate 5 minutes at room temperature
Then add 3.5 J.11 from Reaction tube to each GATC termination tube.
• Incubate at 37°C for 5 minutes.
Then add 4 JlI of stop solution to each termination tube.
Store at -20oC.





Dilute forward and reverse primers separately to 5 J.1M from 50 J.1M primer stock:
2 J.11 of 50 J.1M primer stock (one primer only) + 18 J.11 PCR water
Labelling Reaction:
1.2 J.11 10X kinase buffer
0.8 J.11 T4 Kinase
2.0 J.11 of 5 J.1M primer to be labelled
8.0 J.1I y_32p-ATP
Incubate at 37°C for 30 minutes, then 650C for 10 minutes.
Add:
94 J.11 of PCR water
1a J.1I of each 5 JlM unlabelled primer (forward and reverse)
PCR
Ingredients (25 JlI total volume):
16.1 JlI ddH20
2.5 J.11 10X PCR buffer
.25 J.11 dNTPs
.15 J.11 Taq polymerase
.5 JJI primer mix (includes end-labelled, forward and reverse primers)
Mix reaction ingredients together, adding primer mix last. Aliquot 24 J.1I to PCR
tubes. Then add 1 JlI of 50 ng/J.11 genomic DNA and start the reaction.
Denature PCR products for 5 minutes at BOoC and place on ice before
loading 5 J.LI on a sequencing gel with a known DNA sequencing standard.
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APPENDIX 7
Primer sequences used in peR.
Locus Forward primer, Reference


























Medrano and Aguilar-Cordova, 1990a
Medrano and Aguilar-Cordova, 1990b
Lucy et al., 1991
Moody at al., 1994
Moody and Pomp, 1994
Pomp, unpublished
Pomp, unpublished
Sunden et at, 1993
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Abstract
A polymorphism was identified in the bovine PIT1 gene by digesting
polymerase chain reaction (PCR) products with the restriction enzyme Hintl. This
polymorphism was segregating in five diverse breeds of cattle. PIT1 was
sublocalized to the centromeric region of bovine chromosome 1 by linkage
analysis.
Keywords: PIT1, mapping, genetic marker, bovine, PCR, RFlP
PIT1 has been identified as a pituitary specific transcription factor that
regulates the expression of growth hormone (GH) and prolactin (PRL) genes in
the anterior pituitary (Bodner et al., 1988; Ingraham et al. I 1988; Nelson at a/.•
1988). The objectives of this study were to identify a polymorphism in the
bovine PIT1 gene, determine its chromosomal location, and estimate allelic
frequencies in diverse breeds of cattle.
PIT1 eDNA has been sequenced for cattle (Bodner et al.,1988) and human
(Tatsumi et al., 1992). Ohta et al. (1992b) characterized the human PIT1 gene
and provided exon/intron organization of the human PIT1 gene (personal
. communication). Bovine cDNA sequence (Bodner et al., 1988; EMBL accession
number X12657) corresponding to portions of human exons 5 and 6 was used
to design primers to amplify a region of bovine PIT1 flanking an expected intron
of -1.1-kb. Primer sequences were: 5'-primer. 5'-CAATGAGAAAGTTGGTGC-3';
and 3'-primer: 5'-TCTGCAnCGAGATGCTC-3'.
PCR (15 ,.d final volume) was performed using 50 ng of genomic DNA, 200 J,l
M each dNTP, 0.1 J,lM each primer, 0.5 units of Taq polymerase and PCR
reaction buffer (Tris-HCI, 10 mM; MgCI2, 1.5 mM; KCI, 50 mM; pH 8.3). Thermal
cycling began with an initial cycle of 950 C for 2 min, 550 C for 1 min and 720 C
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for 2 min followed by 29 cycles of 1 min at 94, 55 and 720 C, and concluded with
a final extension at 720 C for 9 min. The reaction resulted in a single product of
-1.35-kb (Figure 1). These primers were also successful in amplifying genomic
DNA from ovine, but not porcine or murine DNA.
A panel of 18 purebred cattle representing Angus, Brahman, Brangus,
Gelbvieh, Hereford, Holstein, Limousin, and Simmental breeds was tested for
polymorphisms in the PIT1 PCR product. Products were digested with 19
different restriction enzymes and separated in 3% ethidium bromide stained
agarose gels. One restriction enzyme. Hinfl. revealed two different alleles (A and
B) from the PIT1 PCR fragment (Figure 1). The remaining 18 restriction
enzymes failed to reveal polymorphisms within the PIT1 PCR product.
No departure from Mendelian inheritance of the PIT1 alleles was observed
in 14 full sib families including 155 offspring. A total of 103 purebred animals
were genotyped to determine allele frequencies in different breeds. Allele A
frequencies of .45, .26, .21 •.18 and.1 0 were observed in Angus (n=19),
Holstein (n=17), Hereford (n=45), Gelbvieh (n=17) and Brahman (n=5) breeds,
respectively, with an overall frequency of .25.
A total of 185 animals representing 14 informative families from the
International Bovine Reference Family Panel (IBRP) was utilized to determine
linkage relationships between PIT1 and previously mapped genes. The PIT1
genotypes obtained on the IBRP were merged with the Cattle Genotypic
Database. All possible pairwise comparisons were performed using CRI-MAP
(v2.4 SunOS). PIT1 was localized on chromosome 1 using the BUILD option of
CRI-MAP and the odds for alternative orders were calculated using the ALL
option (Barendse et aI., 1994).
PIT1 was sublocalized to the centromeric region of bovine chromosome 1,
located midway between TGLA57 and RM95 (Figure 2). This makes a linkage
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group of TGLA49-RM95-PIT1-TGLA57 (log odds of 5.36 over the next best order
TGLA49-PIT1-RM95-TGLA57). The superoxide dismutase 1 gene (S001) is
located proximal to this linkage group (Barendse et at., 1994), but showed no
recombinants to TGLA49.
PIT1 is conserved on human chromosome 3, and more distal to it are other
loci (CRYG8 and UMPS; Barendse et aL, 1993) that are also conserved on
human chromosome 3. More proximal to the centromere is 5001 and COL6A1
(Schmutz at aI., 1994), conserved on human chromosome 21, while other loci
conserved on human chromosome 21 are located much further towards the
telomere of bovine chromosome 1 (O'Brien at aI., 1993). PIT1 thus contributes to
defining the boundary of an evolutionary breakpoint on bovine chromosome 1,
and extends previous mapping efforts (Threadgill at aI., 1991; Barendse et af.,
1993) to understanding the evolutionary conservation of this chromosome.
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Fig. 1. Hintl restriction tra t I
gmen ength polymorphism in bovine PIT1 peR
products.






Lane 1 is the undigested PIT1 PCR product of --1355 bp. Lanes 2, 3 and 4 are
Hinfl digested PIT1 PCR products from cattle of AA (SSQ, 425 and 270 bp), AB
(660,425,385 and 270 bp) and BB (660,385 and 270 bp) genotypes,
respectively. A 40 bp fragment not visible in the gel was likely the result of an
additional Hinfl recognition site in the B allele. Lane 5 is Boehringer Mannheim
(Indianapolis, IN, USA) DNA Molecular Weight Marker VI.
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Fig. 2. SUblocalization of the PIT1 gene to the centromeric region of bovine
chromosome 1. Kosambi eM map distances are shown for a sex averaged
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Polymorphism
Alul polymerase chain reaction restriction fragment length polymorphism
(PCR-RFlP) of the bovine Growth Hormone Receptor (GHR) gene.
Source and Description of Primers
Primers were designed from bovine GHR cDNA sequence (Hauser et aI.,
1990) with consideration of consensus with human axon/intron boundaries
(Godowski et aI., 1989). The amplified products spanned bovine cDNA
nucleotides 946 through 1037 described by Hauser at at (1990). This region of
the bovine GHR gene corresponds to portions of exons 7 and 8 of the human
GHR gene, which are separated by a --3-kb intron (Godowski at al., 1989). peR
amplification of bovine genomic DNA resulted in products of --1945 bp,
indicating the presence of an intron in a similar location but of smaller size than
described for the human GHR gene. The PCR product was sequenced to verify
identity to published bovine eDNA GHR sequence.
Primer Sequence
5' Primer: 5'-CAGATGAACCCATCTGCATGT-3'. 3' Primer: 5'·
AATGTCACTGCTAGCCCAAGT-3'.
Method of Detection
PCR (15 ~I final volume) was performed using 50 ng of bovine genomic
DNA, 200 ~M each dNTP, 0.5 ~M each primer, 0.5 units of Taq polymerase and
PCR reaction buffer (Tris-HCI, 10 mM; MgCI2, 1.5 mM; KCI, 50 mM; pH 8.3).
Thermal cycling began with an initial cycle of 95°C for 2 min, 55°C for 1 min
and 720C for 3 min, followed by 29 cycles of 94°C for 1 min, 55°C for 1 min and
720 C for 3 min, and concluded with a final extension at 72°C for 9 min. PCR
products were digested with 1.25 units of the restriction enzyme Alul in 12 ~I
177
reactions. Digested products were separated in 3% agarose gels stained with
ethidium bromide.
Description of Polymorphism
Alul digestion of the approximately 2.Q-kb peR product of the bovine GHR
gene revealed 2 different alleles (Figure 1). The A allele was characterized by
bands of 785, 670, 375 and 115 bp. The B allele had an additional Alul
restriction site within the 670 bp fragment resulting in bands of 785, 475, 375,
195 and 115 bp.
Inheritance Pattern
Departure from Mendelian inheritance of the two GHR alleles was not
observed in 11 full sib families including 119 offspring.
Frequency
While the A allele of the GHR gene was fixed in a total of 94 animals
representing Hereford, Polled Hereford, Angus, Gelbvieh and Holstein breeds,
the A and B GHR alleles were segregating in cattle of bas indicus descent. Five
unrelated Brahman sires were homozygous for the B allele. Twenty unrelated
animals of at least partial bas indicus descent included as parents in the
International Bovine Reference Family Panel (IBRP) had frequencies of .42 for
the B allele and .58 for the A allele.
Chromosomal location
The bovine GHR gene was mapped to chromosome 20, distal to TGLA126
and proximal to GMBT41 (Barendse et aI., 1994), by linkage analysis utilizing
the IBRP and the cattle genotypic database. Hexosaminidase Band 5-
hydroxytryptamine receptor 1A genes have also been mapped to bovine
chromosome 20 (Barendse et aI., 1994). These genes, along with GHR, have
been mapped in humans to chromosome 5 (see O'Brien et aI., 1993). The
addition of GHR to the bovine map provides further evidence that homology
178
exists between bovine chromosome 20 and human chromosome 5. Collaborative
efforts are underway to determine the chromosomal location of GHR using
physical mapping techniques.
Comments
Growth Hormone Receptor is the cell surface receptor for Growth Hormone
(GH) and is required for GH to carry out its effects on target tissues. It has been
suggested that serum growth hormone-binding protein is also a product of the
GHR gene by a mechanism of alternative splicing (Baumbach et at, 1989).
Mutations in the GHR gene have been associated with sex-linked dwarfism in
chickens (Burnside et aI., 1992) and Laron-type dwarfism in humans (Godowski
at aI., 1989).
This polymorphism should be useful in studies to identify Quantitative Trait
Loci (QTL) in resource populations developed from crosses between bos indicus
and bas taurus cattle. Primers designed to amplify bovine genomic DNA were
also successful in amplifying genomic DNA from sheep, but not from porcine or
murine DNA. Polymorphisms in sheep were not investigated.
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Figure 1. Alul restriction fragment length polymorphism of bovine growth







Undigested and Alul digested GHR PCR products visualized after gel
electrophoresis and ethidium bromide staining are shown. Lane 1 is the GHR
PCR product of ~1945 bp. Lanes 2, 3 and 4 are Alul digested GHR PCR
products from cattle of AA, AB, and BB genotype, respectively, characterized by
banding patterns of 785, 670,375 and 115 bp (AA genotype); 785, 670, 475,
375,195 and 115 bp (AS genotype); and 785.475.375,195 and 115 bp (BB
genotype) (The 115 bp band is faint). Faint monomorphic bands of 1175 and 580
bp are also visible. Lane 5 is a size marker (Boehringer Mannheim DNA
Molecular Weight Marker VI (Indianapolis, IN); sizes: 2176, 1766, 1230, 1033,
653,517,453,394,298,234,220 and 154 bp.)
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APPENDIX 10
Results from EPD Regression Analyses
Figure 1: Regression analyses to estimate the effect of K-Cas allele substitution
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Figure 2: Regression analyses to estimate the effect of B-Lac allele substitution
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Figure 3: Regression analyses to estimate the effed of GH allele substitution on
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Figure 4: Regression analyses to estimate the effect of IGF-I allele substitution
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Figure 5: Regression analyses to estimate the effect of Pit-1 allele substitution
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